false --12-31 Q3 0001166708 P5Y P5Y 0001166708 2024-01-01 2024-09-30 0001166708 2024-11-19 0001166708 2024-09-30 0001166708 2023-12-31 0001166708 us-gaap:NonrelatedPartyMember 2024-09-30 0001166708 us-gaap:NonrelatedPartyMember 2023-12-31 0001166708 us-gaap:RelatedPartyMember 2024-09-30 0001166708 us-gaap:RelatedPartyMember 2023-12-31 0001166708 2024-07-01 2024-09-30 0001166708 2023-07-01 2023-09-30 0001166708 2023-01-01 2023-09-30 0001166708 us-gaap:NonrelatedPartyMember 2024-07-01 2024-09-30 0001166708 us-gaap:NonrelatedPartyMember 2023-07-01 2023-09-30 0001166708 us-gaap:NonrelatedPartyMember 2024-01-01 2024-09-30 0001166708 us-gaap:NonrelatedPartyMember 2023-01-01 2023-09-30 0001166708 us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001166708 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001166708 us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001166708 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001166708 us-gaap:PreferredStockMember 2023-12-31 0001166708 us-gaap:CommonStockMember 2023-12-31 0001166708 BWMG:CommonStockPayableMember 2023-12-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001166708 us-gaap:RetainedEarningsMember 2023-12-31 0001166708 us-gaap:PreferredStockMember 2024-03-31 0001166708 us-gaap:CommonStockMember 2024-03-31 0001166708 BWMG:CommonStockPayableMember 2024-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001166708 us-gaap:RetainedEarningsMember 2024-03-31 0001166708 2024-03-31 0001166708 us-gaap:PreferredStockMember 2024-06-30 0001166708 us-gaap:CommonStockMember 2024-06-30 0001166708 BWMG:CommonStockPayableMember 2024-06-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001166708 us-gaap:RetainedEarningsMember 2024-06-30 0001166708 2024-06-30 0001166708 us-gaap:PreferredStockMember 2022-12-31 0001166708 us-gaap:CommonStockMember 2022-12-31 0001166708 BWMG:CommonStockPayableMember 2022-12-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001166708 us-gaap:RetainedEarningsMember 2022-12-31 0001166708 2022-12-31 0001166708 us-gaap:PreferredStockMember 2023-03-31 0001166708 us-gaap:CommonStockMember 2023-03-31 0001166708 BWMG:CommonStockPayableMember 2023-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001166708 us-gaap:RetainedEarningsMember 2023-03-31 0001166708 2023-03-31 0001166708 us-gaap:PreferredStockMember 2023-06-30 0001166708 us-gaap:CommonStockMember 2023-06-30 0001166708 BWMG:CommonStockPayableMember 2023-06-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001166708 us-gaap:RetainedEarningsMember 2023-06-30 0001166708 2023-06-30 0001166708 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001166708 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001166708 BWMG:CommonStockPayableMember 2024-01-01 2024-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001166708 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001166708 2024-01-01 2024-03-31 0001166708 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001166708 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001166708 BWMG:CommonStockPayableMember 2024-04-01 2024-06-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001166708 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001166708 2024-04-01 2024-06-30 0001166708 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001166708 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001166708 BWMG:CommonStockPayableMember 2024-07-01 2024-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001166708 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001166708 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001166708 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001166708 BWMG:CommonStockPayableMember 2023-01-01 2023-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001166708 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001166708 2023-01-01 2023-03-31 0001166708 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001166708 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001166708 BWMG:CommonStockPayableMember 2023-04-01 2023-06-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001166708 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001166708 2023-04-01 2023-06-30 0001166708 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001166708 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001166708 BWMG:CommonStockPayableMember 2023-07-01 2023-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001166708 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001166708 us-gaap:PreferredStockMember 2024-09-30 0001166708 us-gaap:CommonStockMember 2024-09-30 0001166708 BWMG:CommonStockPayableMember 2024-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001166708 us-gaap:RetainedEarningsMember 2024-09-30 0001166708 us-gaap:PreferredStockMember 2023-09-30 0001166708 us-gaap:CommonStockMember 2023-09-30 0001166708 BWMG:CommonStockPayableMember 2023-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001166708 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001166708 us-gaap:RetainedEarningsMember 2023-09-30 0001166708 2023-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2024-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2023-12-31 0001166708 BWMG:NineHundredFourtyAMember us-gaap:RelatedPartyMember 2024-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2024-09-30 0001166708 BWMG:BlakeCarmichaelMember us-gaap:RelatedPartyMember 2024-09-30 0001166708 BWMG:NineHundredFourtyAMember us-gaap:RelatedPartyMember 2023-12-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2023-12-31 0001166708 BWMG:BlakeCarmichaelMember us-gaap:RelatedPartyMember 2023-12-31 0001166708 BWMG:LicenseAgreementMember 2024-07-01 2024-09-30 0001166708 BWMG:LicenseAgreementMember 2023-07-01 2023-09-30 0001166708 BWMG:LicenseAgreementMember 2024-09-30 0001166708 BWMG:LicenseAgreementMember 2023-12-31 0001166708 BWMG:RobertCarmichaelMember BWMG:PromissoryNoteMember 2022-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2022-09-29 2022-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2024-07-01 2024-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2024-09-30 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-01-18 2023-01-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-02-18 2023-02-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-01-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-02-18 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-09-14 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-09-14 2023-09-14 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2024-09-30 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-07 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-07 2023-11-07 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2024-09-30 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2024-01-01 2024-09-30 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-02-05 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-02-05 2024-02-05 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-09-30 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-01-01 2024-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2024-01-01 2024-09-30 0001166708 BWMG:ConvertibleDebentureMember BWMG:TierraVistaPartnersLLCMember 2024-01-01 2024-09-30 0001166708 BWMG:ConvertibleDebentureOneMember 2024-01-01 2024-09-30 0001166708 BWMG:ConvertibleDebentureOneMember 2024-09-30 0001166708 BWMG:ConvertibleDebentureTwoMember 2024-01-01 2024-09-30 0001166708 BWMG:ConvertibleDebentureTwoMember 2024-09-30 0001166708 BWMG:ConvertibleDebentureThreeMember 2024-01-01 2024-09-30 0001166708 BWMG:ConvertibleDebentureThreeMember 2024-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2021-09-02 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:TierraVistaPartnersLLCMember 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:TierraVistaPartnersLLCMember 2021-09-02 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2022-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2022-09-29 2022-09-30 0001166708 BWMG:SummitHoldingsVLLCNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2024-09-30 0001166708 BWMG:TierraVistaPartnersLLCNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2024-09-30 0001166708 BWMG:RobertCarmichaelNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2024-09-30 0001166708 us-gaap:ConvertibleDebtSecuritiesMember 2024-09-30 0001166708 BWMG:MercedesBenzMember 2024-09-30 0001166708 BWMG:NavitasBLU3Member 2024-09-30 0001166708 BWMG:NFSSSIMember 2024-09-30 0001166708 BWMG:Navitas2022BLU3Member 2024-09-30 0001166708 BWMG:Navitas2024BLU3OneMember 2024-09-30 0001166708 BWMG:Navitas2024BLU3TwoMember 2024-09-30 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2020-08-21 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2020-08-20 2020-08-21 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2024-09-30 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2023-12-31 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2021-05-19 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2021-05-18 2021-05-19 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2024-09-30 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2023-12-31 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2022-06-29 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2022-06-28 2022-06-29 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2024-09-30 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2023-12-31 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2022-12-12 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2022-12-10 2022-12-12 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2024-09-30 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2023-12-31 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2024-02-12 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2024-02-12 2024-02-12 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2024-09-30 0001166708 BWMG:Navitas2024BLU3TwoMember BWMG:InventoryFinanceAgreementMember 2024-09-04 0001166708 BWMG:Navitas2024BLU3TwoMember BWMG:InventoryFinanceAgreementMember 2024-09-04 2024-09-04 0001166708 BWMG:Navitas2024BLU3TwoMember BWMG:InventoryFinanceAgreementMember 2024-09-30 0001166708 us-gaap:TrademarksMember 2024-09-30 0001166708 us-gaap:CustomerRelationshipsMember 2024-09-30 0001166708 us-gaap:NoncompeteAgreementsMember 2024-09-30 0001166708 BWMG:MrCharlesFHyattMember 2023-01-18 2023-01-18 0001166708 BWMG:MrCharlesFHyattMember 2023-02-18 2023-02-18 0001166708 BWMG:MrCharlesFHyattMember 2023-01-18 0001166708 BWMG:MrCharlesFHyattMember 2023-02-18 0001166708 BWMG:RobertCarmichaelMember 2023-01-01 2023-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2023-01-01 2023-03-31 0001166708 BWMG:RobertCarmichaelMember 2023-04-01 2023-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2023-04-01 2023-06-30 0001166708 BWMG:RobertCarmichaelMember 2023-07-01 2023-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2023-07-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember 2023-10-01 2023-12-31 0001166708 BWMG:ConvertibleNotesHolderMember 2023-10-01 2023-12-31 0001166708 BWMG:RobertCarmichaelMember 2024-01-01 2024-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2024-01-01 2024-03-31 0001166708 BWMG:RobertCarmichaelMember 2024-04-01 2024-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2024-04-01 2024-06-30 0001166708 2010-06-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember 2011-04-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember 2011-04-01 2011-04-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember BWMG:RobertCarmichaelMember 2024-09-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember BWMG:RobertCarmichaelMember 2023-12-31 0001166708 BWMG:EquityIncentivePlanMember 2021-05-26 0001166708 us-gaap:EmployeeStockOptionMember 2024-09-30 0001166708 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001166708 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001166708 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-09-30 0001166708 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0001166708 us-gaap:OptionMember 2024-09-30 0001166708 us-gaap:OptionMember 2024-01-01 2024-09-30 0001166708 BWMG:EquityCompensationApprovedPlanMember BWMG:SecurityHoldersMember 2024-09-30 0001166708 BWMG:EquityCompensationNotApprovedPlanMember BWMG:SecurityHoldersMember 2024-09-30 0001166708 srt:MinimumMember 2024-01-01 2024-09-30 0001166708 srt:MaximumMember 2024-01-01 2024-09-30 0001166708 srt:MinimumMember 2023-01-01 2023-09-30 0001166708 srt:MaximumMember 2023-01-01 2023-09-30 0001166708 2022-01-01 2022-12-31 0001166708 2023-01-01 2023-12-31 0001166708 BWMG:ExercisePriceRangeOneMember 2024-01-01 2024-09-30 0001166708 BWMG:ExercisePriceRangeOneMember 2024-09-30 0001166708 BWMG:ExercisePriceRangeTwoMember 2024-01-01 2024-09-30 0001166708 BWMG:ExercisePriceRangeTwoMember 2024-09-30 0001166708 BWMG:ExercisePriceRangeThreeMember 2024-01-01 2024-09-30 0001166708 BWMG:ExercisePriceRangeThreeMember 2024-09-30 0001166708 us-gaap:WarrantMember 2023-12-31 0001166708 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001166708 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001166708 us-gaap:WarrantMember 2024-09-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2022-01-01 2022-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2023-01-01 2023-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember srt:ScenarioForecastMember 2024-01-01 2024-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:DecemberThirtyOneTwoThousandAndTwentyThreeMember 2020-06-28 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:YearsTwoThousandAndNineteenThroughTwoThousandAndTwentyFourMember 2020-06-28 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2024-01-01 2024-09-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2023-01-01 2023-09-30 0001166708 BWMG:BlakeCarmichaelAgreementMember 2021-08-01 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementMember 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember srt:MaximumMember 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember 2021-08-01 0001166708 BWMG:BubanAgreementMember 2021-08-30 2021-09-03 0001166708 BWMG:BubanAgreementMember 2021-09-03 0001166708 BWMG:BubanAgreementMember srt:MaximumMember 2021-09-03 0001166708 BWMG:BubanAgreementMember BWMG:FiveYearStockOptionMember 2021-09-03 0001166708 BWMG:CroneLawGroupMember 2022-01-16 2022-01-17 0001166708 BWMG:GagasEmploymentAgreementMember 2022-05-01 2022-05-02 0001166708 2022-05-01 2022-05-02 0001166708 2022-05-02 0001166708 2022-09-13 2022-09-14 0001166708 2022-09-14 0001166708 2022-09-29 2022-09-30 0001166708 2022-09-30 0001166708 2022-12-20 2022-12-22 0001166708 us-gaap:SubsequentEventMember BWMG:TwentyTwentyThreeNoteMember 2024-11-13 0001166708 us-gaap:SubsequentEventMember BWMG:TwentyTwentyThreeNoteMember srt:MinimumMember 2024-11-13 2024-11-14 0001166708 us-gaap:SubsequentEventMember BWMG:TwentyTwentyThreeNoteMember srt:MaximumMember 2024-11-13 2024-11-14 0001166708 us-gaap:SubsequentEventMember BWMG:TwentyTwentyFourNoteMember 2024-11-13 0001166708 us-gaap:SubsequentEventMember BWMG:TwentyTwentyFourNoteMember srt:MinimumMember 2024-11-13 2024-11-14 0001166708 us-gaap:SubsequentEventMember BWMG:TwentyTwentyFourNoteMember srt:MaximumMember 2024-11-13 2024-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft BWMG:Integer

false --12-31 Q1 0001166708 0001166708 2025-01-01 2025-03-31 0001166708 2025-06-27 0001166708 2025-03-31 0001166708 2024-12-31 0001166708 us-gaap:NonrelatedPartyMember 2025-03-31 0001166708 us-gaap:NonrelatedPartyMember 2024-12-31 0001166708 us-gaap:RelatedPartyMember 2025-03-31 0001166708 us-gaap:RelatedPartyMember 2024-12-31 0001166708 2024-01-01 2024-03-31 0001166708 us-gaap:NonrelatedPartyMember 2025-01-01 2025-03-31 0001166708 us-gaap:NonrelatedPartyMember 2024-01-01 2024-03-31 0001166708 us-gaap:RelatedPartyMember 2025-01-01 2025-03-31 0001166708 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001166708 us-gaap:PreferredStockMember 2024-12-31 0001166708 us-gaap:CommonStockMember 2024-12-31 0001166708 BWMG:CommonStockPayableMember 2024-12-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001166708 us-gaap:RetainedEarningsMember 2024-12-31 0001166708 us-gaap:PreferredStockMember 2023-12-31 0001166708 us-gaap:CommonStockMember 2023-12-31 0001166708 BWMG:CommonStockPayableMember 2023-12-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001166708 us-gaap:RetainedEarningsMember 2023-12-31 0001166708 2023-12-31 0001166708 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001166708 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001166708 BWMG:CommonStockPayableMember 2025-01-01 2025-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001166708 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001166708 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001166708 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001166708 BWMG:CommonStockPayableMember 2024-01-01 2024-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001166708 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001166708 us-gaap:PreferredStockMember 2025-03-31 0001166708 us-gaap:CommonStockMember 2025-03-31 0001166708 BWMG:CommonStockPayableMember 2025-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001166708 us-gaap:RetainedEarningsMember 2025-03-31 0001166708 us-gaap:PreferredStockMember 2024-03-31 0001166708 us-gaap:CommonStockMember 2024-03-31 0001166708 BWMG:CommonStockPayableMember 2024-03-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001166708 us-gaap:RetainedEarningsMember 2024-03-31 0001166708 2024-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2025-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2024-12-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2025-03-31 0001166708 BWMG:BlakeCarmichaelMember us-gaap:RelatedPartyMember 2025-03-31 0001166708 BWMG:NineHundredFourtyAMember us-gaap:RelatedPartyMember 2024-12-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2024-12-31 0001166708 BWMG:BlakeCarmichaelMember us-gaap:RelatedPartyMember 2024-12-31 0001166708 BWMG:LicenseAgreementMember 2025-01-01 2025-03-31 0001166708 BWMG:LicenseAgreementMember 2024-01-01 2024-03-31 0001166708 BWMG:LicenseAgreementMember 2025-03-31 0001166708 BWMG:LicenseAgreementMember 2024-12-31 0001166708 BWMG:RobertCarmichaelMember BWMG:PromissoryNoteMember 2022-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2022-09-29 2022-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2025-03-31 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-01-18 2023-01-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-02-18 2023-02-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-01-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-02-18 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-09-14 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-09-14 2023-09-14 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2025-03-31 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-14 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-14 2023-11-14 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-02-05 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-02-05 2024-02-05 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2024-07-16 2024-07-16 0001166708 BWMG:DavisNatanlMember us-gaap:CommonStockMember 2024-08-15 2024-08-15 0001166708 BWMG:BlakeCarmichaelMember us-gaap:CommonStockMember 2024-12-09 2024-12-09 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertibleDebentureMember BWMG:TierraVistaPartnersLLCMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableOneMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableOneMember 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableTwoMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableTwoMember 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableThreeMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableThreeMember 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableFourMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableFourMember 2025-03-31 0001166708 BWMG:ConvertiblePromissoryNotePayableMember 2025-03-31 0001166708 BWMG:SummitHoldingsVLLCNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0001166708 BWMG:TierraVistaPartnersLLCNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0001166708 BWMG:RobertCarmichaelLBINoteMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0001166708 BWMG:RobertCarmichaelBLU3NoteMember us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0001166708 us-gaap:ConvertibleDebtSecuritiesMember 2025-03-31 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2021-09-02 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:TierraVistaPartnersLLCMember 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:TierraVistaPartnersLLCMember 2021-09-02 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2022-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2022-09-29 2022-09-30 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-12-31 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2024-12-31 0001166708 BWMG:CharlesHyattMember BWMG:BLU3IncMember 2023-11-14 0001166708 BWMG:CharlesHyattMember BWMG:BLU3IncMember 2023-11-14 2023-11-14 0001166708 BWMG:CharlesHyattMember BWMG:BLU3IncMember 2024-12-31 0001166708 BWMG:CharlesHyattMember BWMG:BLU3IncMember 2024-01-01 2024-12-31 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-12-31 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2024-01-01 2024-12-31 0001166708 BWMG:MercedesBenzMember 2025-03-31 0001166708 BWMG:NavitasTwoThousandTwentyOneBLU3Member 2025-03-31 0001166708 BWMG:NFSSSIMember 2025-03-31 0001166708 BWMG:Navitas2022BLU3Member 2025-03-31 0001166708 BWMG:Navitas2024BLU3OneMember 2025-03-31 0001166708 BWMG:Navitas2024BTLMember 2025-03-31 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2020-08-21 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2020-08-21 2020-08-21 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2024-03-31 0001166708 BWMG:MercedesBenzMember BWMG:InstallmentAgreementMember 2023-12-31 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2021-05-19 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2021-05-19 2021-05-19 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2024-03-31 0001166708 BWMG:NavitasCreditCorpMember BWMG:EquipmentFinanceAgreementMember 2023-12-31 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2022-06-29 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2022-06-29 2022-06-29 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2024-03-31 0001166708 BWMG:NFSSSIMember BWMG:EquipmentFinancingAgreementMember 2023-12-31 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2022-12-12 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2022-12-12 2022-12-12 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2024-03-31 0001166708 BWMG:Navitas2022BLU3Member BWMG:EquipmentFinanceAgreementMember 2023-12-31 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2024-02-12 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2024-02-12 2024-02-12 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2024-03-31 0001166708 BWMG:Navitas2024BLU3TwoMember BWMG:InventoryFinanceAgreementMember 2024-09-04 0001166708 BWMG:Navitas2024BLU3TwoMember BWMG:InventoryFinanceAgreementMember 2024-09-04 2024-09-04 0001166708 BWMG:Navitas2024BLU3TwoMember BWMG:InventoryFinanceAgreementMember 2024-09-30 0001166708 us-gaap:TrademarksMember 2025-03-31 0001166708 us-gaap:CustomerRelationshipsMember 2025-03-31 0001166708 us-gaap:NoncompeteAgreementsMember 2025-03-31 0001166708 BWMG:MrCharlesFHyattMember 2023-01-18 2023-01-18 0001166708 BWMG:MrCharlesFHyattMember 2023-02-18 2023-02-18 0001166708 BWMG:MrCharlesFHyattMember 2023-01-18 0001166708 BWMG:MrCharlesFHyattMember 2023-02-18 0001166708 BWMG:RobertCarmichaelMember 2023-03-31 2023-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2023-01-01 2023-03-31 0001166708 BWMG:RobertCarmichaelMember 2023-04-01 2023-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2023-04-01 2023-06-30 0001166708 BWMG:RobertCarmichaelMember 2023-07-01 2023-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2023-07-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember 2023-10-01 2023-12-31 0001166708 BWMG:ConvertibleNotesHolderMember 2023-10-01 2023-12-31 0001166708 BWMG:RobertCarmichaelMember 2024-01-01 2024-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2024-01-01 2024-03-31 0001166708 BWMG:RobertCarmichaelMember 2024-04-01 2024-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2024-04-01 2024-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2024-08-15 2024-08-15 0001166708 BWMG:ConvertibleNotesHolderMember 2024-09-30 2024-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2024-12-01 2024-12-31 0001166708 BWMG:ConvertibleNotesHolderMember 2025-01-01 2025-03-31 0001166708 2010-06-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember 2011-04-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember 2011-04-01 2011-04-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember BWMG:RobertCarmichaelMember 2025-03-31 0001166708 BWMG:SeriesAConvertiblePreferredStockMember BWMG:RobertCarmichaelMember 2024-12-31 0001166708 BWMG:EquityIncentivePlanMember 2021-05-26 0001166708 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-12-31 0001166708 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001166708 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0001166708 us-gaap:OptionMember 2024-12-31 0001166708 us-gaap:OptionMember 2024-01-01 2024-12-31 0001166708 us-gaap:OptionMember 2025-01-01 2025-03-31 0001166708 BWMG:EquityCompensationApprovedPlanMember BWMG:SecurityHoldersMember 2025-03-31 0001166708 BWMG:EquityCompensationNotApprovedPlanMember BWMG:SecurityHoldersMember 2025-03-31 0001166708 2025-01-01 2025-12-31 0001166708 2024-01-01 2024-12-31 0001166708 srt:MinimumMember 2025-01-01 2025-12-31 0001166708 srt:MaximumMember 2025-01-01 2025-12-31 0001166708 srt:MinimumMember 2024-01-01 2024-12-31 0001166708 srt:MaximumMember 2024-01-01 2024-12-31 0001166708 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-12-31 0001166708 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2025-01-01 2025-12-31 0001166708 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2025-01-01 2025-12-31 0001166708 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0001166708 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0001166708 2022-12-31 0001166708 2022-01-01 2022-12-31 0001166708 2023-01-01 2023-12-31 0001166708 BWMG:ExercisePriceRangeOneMember 2024-01-01 2024-12-31 0001166708 BWMG:ExercisePriceRangeOneMember 2024-12-31 0001166708 BWMG:ExercisePriceRangeTwoMember 2024-01-01 2024-12-31 0001166708 BWMG:ExercisePriceRangeTwoMember 2024-12-31 0001166708 BWMG:ExercisePriceRangeThreeMember 2024-01-01 2024-12-31 0001166708 BWMG:ExercisePriceRangeThreeMember 2024-12-31 0001166708 us-gaap:WarrantMember 2022-12-31 0001166708 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001166708 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001166708 us-gaap:WarrantMember 2023-12-31 0001166708 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001166708 us-gaap:WarrantMember 2024-12-31 0001166708 2014-08-14 0001166708 2014-08-14 2014-08-14 0001166708 2016-12-01 2016-12-01 0001166708 2018-01-04 0001166708 2018-01-04 2018-01-04 0001166708 2018-11-11 0001166708 2018-11-11 2018-11-11 0001166708 2022-05-02 2022-05-02 0001166708 2022-09-14 2022-09-14 0001166708 2022-09-14 0001166708 2022-09-30 2022-09-30 0001166708 BWMG:InovarPackagingLLCMember 2024-11-01 0001166708 BWMG:InovarPackagingLLCMember srt:MinimumMember 2024-11-01 2024-11-01 0001166708 BWMG:InovarPackagingLLCMember srt:MaximumMember 2024-11-01 2024-11-01 0001166708 BWMG:InovarPackagingLLCMember 2024-11-01 2024-11-01 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2020-06-30 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2019-12-01 2019-12-31 0001166708 2019-12-01 2019-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2024-01-01 2024-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:DecemberThirtyOneTwoThousandAndTwentyThreeMember 2020-06-30 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:YearsTwoThousandAndNineteenThroughTwoThousandAndTwentyFourMember 2020-06-30 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2024-01-01 2024-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:QuarterTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2024-01-01 2024-12-31 0001166708 BWMG:STSAgreementMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2024-01-24 2024-01-24 0001166708 BWMG:STSAgreementMember BWMG:QuarterTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFiveMember 2024-01-24 2024-01-24 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2022-11-01 2022-11-01 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2025-01-01 2025-03-31 0001166708 BWMG:ConstableEmploymentAgreementMember 2020-11-05 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember 2021-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember BWMG:FourYearStockOptionMember 2020-11-05 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember BWMG:FourYearStockOptionMember 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember BWMG:FourConsecutiveFiscalQuartersOneMember 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember BWMG:FourConsecutiveFiscalQuartersOneMember 2020-11-05 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember BWMG:FourConsecutiveFiscalQuartersTwoMember 2020-11-05 0001166708 BWMG:ConstableEmploymentAgreementMember BWMG:FourConsecutiveFiscalQuartersTwoMember 2020-11-05 2020-11-05 0001166708 BWMG:BlakeCarmichaelAgreementMember 2021-08-01 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementMember 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember 2021-08-01 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember srt:MaximumMember 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember 2021-08-01 0001166708 BWMG:BubanAgreementMember 2021-09-03 2021-09-03 0001166708 BWMG:BubanAgreementMember 2021-09-03 0001166708 BWMG:BubanAgreementMember srt:MaximumMember 2021-09-03 0001166708 BWMG:BubanAgreementMember BWMG:FiveYearStockOptionMember 2021-09-03 0001166708 BWMG:GagasEmploymentAgreementMember 2022-05-02 2022-05-02 0001166708 BWMG:CroneLawGroupMember 2022-01-17 2022-01-17 0001166708 2022-12-22 2022-12-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft BWMG:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended ~~September~~March 3031, ~~2024~~2025

	☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

		For the transition period from to

Commission file number 333-99393

BROWNIE’S MARINE GROUP, INC.

(Exact name of registrant as specified in its charter)

Florida		90-0226181
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

3001 NW 25th Avenue, Suite 1 Pompano Beach, Florida		33069
4061 SW, 47th Avenue, Davie, Florida		33314
(Address of principal executive offices)		(Zip code)

(954) 462-5570

Registrant’s telephone number, including area code

Not applicable

Former name, former address and former fiscal year, if changed since last report

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		Not applicable		Not applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of ~~November~~June 1927, ~~2024~~2025, there were 439,~~186~~805,~~662~~747 shares of common stock outstanding.

	TABLE OF CONTENTS
		Page No.
	PART I – FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS.	4
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	24
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	28
ITEM 4.	CONTROLS AND PROCEDURES.	28
	PART II – OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS.	30
ITEM 1A.	RISK FACTORS.	30
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	30
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	30
ITEM 4.	MINE SAFETY DISCLOSURES.	30
ITEM 5.	OTHER INFORMATION.	30
ITEM 6.	EXHIBITS.	31

TABLE OF CONTENTS

		Page No.
	PART I – FINANCIAL INFORMATION

ITEM 1.	FINANCIAL STATEMENTS.	4

	PART II – OTHER INFORMATION

ITEM 1.	LEGAL PROCEEDINGS.	24

ITEM 1A.	RISK FACTORS.	24

ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	24

ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	24

ITEM 4.	MINE SAFETY DISCLOSURES.	24

ITEM 5.	OTHER INFORMATION.	24

ITEM 6.	EXHIBITS.	25

NOTE REGARDING FORWARD-LOOKING INFORMATION

This Quarterly Report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward- looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs.

You should read thoroughly this Quarterly Report with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by risk factors included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on May 9, 2024, which risk factors could adversely impact our business and financial performance. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements speak only as of the date on which they are made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made, except as required by applicable law.

PART I

ITEM 1. FINANCIAL STATEMENTS

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	September 30, 2024			December 31, 2023
	March 31, 2025			December 31, 2024
	(Unaudited)
ASSETS
Current Assets
Cash	$	~~646~~341,~~480~~038		$	~~431~~417,~~112~~678
Accounts receivable – net of allowances of $23,665 in 2024 and $54,427 in 2023		419,829			84,140
Accounts receivable – net of allowances of $17,933 in 2025 and $52,660 in 2024		250,896			180,496
Accounts receivable - related parties		6719,~~632~~853			3241,~~130~~686
Accounts receivable		6719,~~632~~853			3241,~~130~~686
Inventory, net		12,~~967~~200,~~088~~553			12,~~998~~062,~~807~~279
Prepaid expenses and other current assets		~~554~~133,~~187~~426			~~190~~328,~~412~~785
Total current assets		32,~~655~~945,~~216~~766			23,~~736~~030,~~601~~924
Property, equipment and leasehold improvements, net		~~294~~302,~~016~~082			~~342~~303,~~681~~498
Operating lease right-of-use assets		656,202			844,083
Operating lease assets		1,538,491			1,629,192
Intangible assets, net		~~519~~495,~~605~~449			~~573~~501,~~955~~489
Goodwill		249,986			249,986
Other assets		2551,~~825~~826			3051,~~724~~826
Total assets	$	5,~~400~~583,~~850~~600		$	45,~~778~~766,~~030~~915
Liabilities and stockholders’ equity
Current liabilities
Accounts payable and accrued liabilities	$	~~849~~655,~~581~~900		$	~~789~~675,~~702~~950
Accounts payable - related parties		5618,~~993~~889			4618,~~578~~448
Customer deposits and unearned revenue		~~695~~317,~~075~~046			~~255~~410,~~740~~636
Other liabilities		~~474~~442,~~794~~175			~~451~~386,~~954~~402
Operating lease liabilities		~~161~~418,~~277~~327			~~259~~394,~~154~~672
Related party convertible demand note, net		5739,~~296~~088			5238,~~484~~772
Convertible notes		~~350~~360,~~000~~868			~~346~~360,~~871~~561
Current maturities long term debt		801,~~395~~241			7570,~~304~~308
Related party notes payable		~~505~~544,~~000~~088			~~225~~505,000
Total current liabilities		32,~~230~~797,~~411~~622			2,~~502~~860,~~787~~749
Loans payable, net of current portion		7791,~~273~~398			6446,~~656~~763
Operating lease liabilities		~~527~~1,~~502~~163,249			~~615~~1,~~915~~279,444
Total liabilities		34,~~835~~052,~~186~~269			34,~~183~~186,~~358~~956
Commitments and contingent liabilities (see note 8)		-			-
Stockholders’ equity
Preferred stock; $0.001 par value: 10,000,000 shares authorized; 425,000 issued and outstanding as of September 30, 2024 and December 31, 2023.		425			425
Preferred stock; $0.001 par value: 10,000,000 shares authorized; 425,000 issued and outstanding as of March 31, 2024 and December 31, 2023.		425			425
Common stock; $0.0001 par value; 1,000,000,000 shares authorized; 439,323,188 and 437,742,050 shares issued and outstanding at September 30, 2024 and at December 31, 2023, respectively.		43,933			43,775
Common stock; $0.0001 par value; 1,000,000,000 shares authorized; 449,567,462 shares issued and outstanding at March 31, 2025 and 449,430,935 shares issued and outstanding at December 31, 2024, respectively.		43,795			44,951
Common stock payable 138,941 shares and 138,941 shares, as of September 30, 2024 and December 31, 2023, respectively.		14			14
Common stock payable 138,941 shares and 138,941 shares, respectively as of March 31, 2025 and December 31, 2024.		14			14
Additional paid-in capital		19,~~288~~467,~~840~~774			19,~~236~~461,~~068~~898
Accumulated deficit		(17,~~767~~980,~~548~~677	)		(17,~~685~~927,~~610~~329	)
Total stockholders’ equity	$	1,~~565~~531,~~664~~331		$	1,~~594~~579,~~672~~960
Total liabilities and stockholders’ equity	$	5,~~400~~583,~~850~~600		$	45,~~778~~766,~~030~~915

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31,

(unaudited)

	2024			2023			2024			2023
	2025			2024
	Three months ended September 30						Nine months ended September 30
Net revenues
	2024			2023			2024			2023
Net revenues	$	1,320,004		$	1,492,299
Revenues
Net revenues - related parties		209,198			115,223
Revenues	$	2,441,304		$	2,027,592		$	6,147,102		$	5,321,577
Net revenues		209,198			115,223
Revenues - related parties		27,601			254,414			318,951			671,194
Total net revenues		1,529,202			1,607,522
Revenues		27,601			254,414			318,951			671,194
Cost of net revenues
Total Revenues		2,468,905			2,282,006			6,466,053			5,992,771
Cost of net revenues		923,287			889,918
Cost of revenues
Cost of net revenues - related parties		72,264			53,124
Cost of revenues		1,332,610			1,372,755			3,556,055			3,734,350
Cost of net revenues		72,264			53,124
Cost of revenues - related parties		11,579			116,976			140,671			325,037
Royalties expense - related parties		3,992			9,061
Cost of revenues		11,579			116,976			140,671			325,037
Royalties expense		25,629			67,984
Royalties expense - related parties		24,021			23,569			45,073			49,264
Total cost of revenues		1,025,172			1,020,087
Royalties expense		(2,657	)		31,335			102,746			107,308
Gross profit		504,030			587,435
Total cost of revenues		1,365,553			1,544,635			3,844,545			4,215,959
Operating expenses
Gross profit		1,103,352			737,371			2,621,508			1,776,812
Selling, general and administrative		548,126			899,821
Operating expenses
Research and development costs		1,142			3,378
Selling, general and administrative		913,370			807,789			2,636,161			2,326,390
Total operating expenses		549,268			903,199
Research and development costs		40			7,355			10,197			10,778
Loss from operations		(45,238	)		(315,764	)
Total operating expenses		913,410			815,144			2,646,358			2,337,168
Other (income) expense, net		-			-
Income (loss) from operations		189,943			(77,773	)		(24,850	)		(460,356	)
Other Income		18,849			-
Other (income) expense, net
Interest expense		(28,080	)		(19,952	)
Interest expense		(16,000	)		(20,776	)		(57,088	)		(55,959	)
Total other (income) expense - net		(9,231	)		(19,952	)
Income (Loss) before provision for income taxes		173,943			(98,549	)		(81,938	)		(616,315	)
Loss income before provision for income taxes		(54,468	)		(335,716	)
Provision for income taxes		-			-			-			-
Net Income (Loss)	$	173,943		$	(98,549	)	$	(81,938	)	$	(616,315	)
Net loss	$	(54,468	)	$	(335,716	)
Basic income (loss) per common share	$	0.00		$	(0.00	)	$	(0.00	)	$	(0.00	)
Basic loss per common share	$	(0.00	)	$	(0.00	)
Basic weighted average common shares outstanding		438,138,458			437,196,851			438,341,018			433,169,015
Diluted loss per common share	$	(0.00	)	$	(0.00	)
Diluted income (loss) per common share	$	0.00		$	(0.00	)	$	(0.00	)	$	(0.00	)
Basic weighted average common shares outstanding		449,430,935			438,937,858
Diluted weighted average common shares outstanding		~~496~~449,~~928~~430,~~553~~935			~~437~~438,~~196~~937,~~851~~858			~~438,341,018~~			~~433,169,015~~

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN ~~STOCKHOLDERS’~~SHAREHOLDERS EQUITY

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER~~MARCH 3031, ~~2024~~2025 AND ~~2023~~2024

(unaudited)

	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Income (Loss)			Deficit			Equity
	Outstanding		Par		Outstanding		Par		Shares		Amount		Capital		Deficit			Equity
	Preferred Stock				Common Stock				Common Stock Payable				Additional ~~Paid-in~~		~~Accumulated Other Comprehensive~~			~~Accumulated~~Total			~~Total Stockholder’s~~
	Shares		~~Amount~~		Shares		~~Amount~~		~~Shares~~		~~Amount~~		~~Capital~~Paid-in		~~Income (Loss)~~Accumulated			~~Deficit~~Stockholders			~~Equity~~
December 31, 2023		425,000	$	425.00		437,742,050	$	43,775		138,941	$	14	$	19,236,068	$	-		$	(17,685,610	)	$	1,594,672
	Outstanding		Par		Outstanding		Par		Shares		Amount		Capital		Deficit			Equity
Shares issued for accrued interest on convertible notes		-		-		198,204		20		-		-		10,987		-			-			11,007
Balance, December 31, 2024		425,000	$	425		449,430,935	$	44,944		138,941	$	14	$	19,460,786	$	(17,926,209	)	$	1,579,960
Stock Option Expense		-		-		-		-		-		-		12,423		-			-			12,423
Shares issued for accrued interest in convertible notes		-		-		136,527		14		-				6,988		-			7,002
Net Loss		-		-		-		-		-		-		-		-			(335,716	)		(335,716	)
Stock Option Expense		-		-		-		-		-		-				-			(1,163	)
March 31, 2024 (unaudited)		425,000		425		437,940,254		43,795		138,941		14		19,259,478	$	-			(18,021,326	)		1,282,386
Net Loss		-		-		-		-		-		-		-		(54,468	)		(54,468	)
Shares issued for accrued interest on convertible notes		-		-		259,881		26		-		-		6,974		-			-			7,000
Balance, March 31, 2025 (unaudited)		425,000		425		449,567,462	$	44,958		138,941	$	14	$	19,467,774	$	(17,980,677	)	$	1,531,331
Net Income		-		-		-		-		-		-		-		-			79,835			79,835
June 30, 2024 (unaudited)		425,000	$	425		438,200,135	$	43,821		138,941	$	14	$	19,266,452	$	-		$	(17,941,491	)	$	1,369,221
Shares issued for accrued interest on convertible notes		-		-		1,123,053		112		-		-		22,388		-			-			22,500
Net Income		-		-		-		-		-		-		-		-			173,943			173,943
September 30, 2024 (unaudited)		425,000	$	425		439,323,188	$	43,933		138,941	$	14	$	19,288,840	$	-		$	(17,767,548	)	$	1,565,664

	Preferred Stock				Common Stock				Common Stock Payable				Additional ~~Paid-in~~		~~Accumulated Other Comprehensive~~			~~Accumulated~~Total			~~Total Stockholder’s Equity~~
	Shares		~~Amount~~		Shares		~~Amount~~		~~Shares~~		~~Amount~~		~~Capital~~Paid-in		~~Income (Loss)~~Accumulated			~~Deficit~~Stockholders			~~(DEFICIT)~~
December 31, 2022		425,000	$	425.00		425,520,662	$	42,553		138,941	$	14	$	18,916,876	$	-		$	(16,437,495	)	$	2,522,373
	Outstanding		Par		Outstanding		Par		Shares		Amount		Capital		Deficit			Equity
Shares issued for the purchase of units		-		-		11,428,570		1,143		-		-		198,857		-			-			200,000
Balance, December 31, 2023		425,000		425		437,742,050	$	43,775		138,941	$	14	$	19,236,068	$	(17,685,610	)	$	1,594,672
Shares issued for accrued interest on convertible notes		-		-		198,204		20		-		-		8,316		-			-			8,336
Balance		425,000		425		437,742,050	$	43,775		138,941	$	14	$	19,236,068	$	(17,685,610	)	$	1,594,672
Stock Option Expense		-		-		-		-		-		-		11,034		-			-			11,034
Shares issued for the purchase of units		-		-						-		-				-
Net Loss		-		-		-		-		-		-		-		-			(327,922	)		(327,922	)
Shares issued for accrued interest in convertible notes		-		-		198,204		20		-		-		10,987		-			11,007
March 31, 2023 (unaudited)		425,000		425		437,147,436		43,716		138,941		14		19,135,083	$	-			(16,765,417	)		2,413,821
Stock Option Expense		-		-		-		-		-		-		12,423		-			12,423
Shares issued for accrued interest on convertible notes		-		-		198,205		20		-		-		8,306		-			-			8,326
Net Loss		-		-		-		-		-		-		-		(335,716	)		(335,716	)
Stock option expense		-		-		-		-		-		-		7,188		-			-			7,188
Balance, March 31, 2024 (unaudited)		425,000		425		437,940,254	$	43,795		138,941	$	14	$	19,259,478	$	(18,021,326	)	$	1,282,386
Net loss		-		-		-		-		-		-		-		-			(189,844	)		(189,844	)
Balance		425,000		425		437,940,254	$	43,795		138,941	$	14	$	19,259,478	$	(18,021,326	)	$	1,282,386
June 30, 2023 (unaudited)		425,000	$	425		437,345,641	$	43,736		138,941	$	14	$	19,150,577	$	-		$	(16,955,261	)	$	2,239,491
Shares issued for accrued interest on convertible notes						198,205		19						6,983								7,002
Stock option expense														7,185								7,185
Net loss																			(98,549	)		(98,549	)
Net income (loss)				-				-				-		-		-			(98,549	)		(98,549	)
September 30, 2023 (unaudited)		425,000	$	425		437,543,846	$	43,755		138,941	$	14	$	19,164,745	$	-		$	(17,053,810	)	$	2,155,129

The accompanying ~~condensed~~ notes are an integral part of these unaudited consolidated financial statements

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

~~CONSOLIDATED~~CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE ~~NINE~~THREE MONTHS ENDED ~~SEPTEMBER~~MARCH 3031,

(unaudited)

	2024			2023
	2025			2024
Cash flows from operating activities:
Cash flows provided by operating activities:
Net loss	$	(8154,~~938~~468	)	$	(~~616~~335,~~315~~716	)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization		~~120~~7,~~878~~456			~~121~~39,~~343~~202
Amortization of debt discount		~~7,941~~623			72,~~786~~526	)
Amortization of right-of-use asset		~~187~~90,~~881~~701			~~191~~66,~~378~~605
Allowance for Nomad recall		-			(93,161	)
Common Stock Issued for services
Stock Based Compensation - Options		12,423			25,404
Reserve for Nomad recall		(86,300	)
Shares issued for interest on convertible notes		40,508			23,668
Stock Based Compensation - Options					12,423
Stock based compensation - stock grant		-
Shares issued for convertible notes		5,839			11,007
Changes in operating assets and liabilities
Change in accounts receivable, net		(~~335~~70,~~689~~400	)		(~~128~~77,~~197~~914	)
Change in accounts receivable - related parties		~~(35~~21,~~502~~833	)		79,~~687~~025
Change in inventory		31(138,~~719~~274	)		~~375~~31,~~814~~535
Change in prepaid expenses and other current assets		~~(363~~195,~~775~~359	)		(~~101~~76,~~804~~792	)
Change in other assets		(4,899	)		-
Recovery of bad debt		-			-
Change in accounts payable and accrued liabilities		77,587			(238,260	)
Change in reserve of slow moving inventory		-			-
Change in customer deposits and unearned revenue		439,335			177,455
Change in other assets		-			-
Change in long term lease liability		(186,290	)		(186,951	)
Change in ROU assets		-			-
Change in other liabilities		22,839			66,854
Change in accounts payable and accrued liabilities		(44,482	)		(57,296	)
Change in accounts payable - related parties		10,415			(329	)
Change in customer deposits and unearned revenue		(93,590	)		(50,835
Net cash used in operating activities		(56,567	)		(367,628	)
Change in long term lease liability		(92,540	)		(66,075	)
Cash flows from investing activities:
Change in other liabilities		142,073			20,346
Purchase of fixed assets		(14,251	)		(28,671	)
Change in accounts payable - related parties		441			5,595	)
Net cash used in investing activities		(14,251	)		(28,671	)
Net cash used in operating activities		(115,729	)		(466,364	)
Cash flows used in investing activities:
Purchase of fixed assets		-			(5,995	)
Net cash used in investing activities					(5,995	)
Cash flows from financing activities:
Proceeds from issuance of units		-			~~200~~280,000
Proceeds of related party demand note		~~280~~39,~~000~~088			~~50,000~~-
Proceeds of long term debt		32,274			-
Proceeds from long term debt		-			-
Repayment of debt		~~(26,087~~-	)		~~(50,260~~-	)
Net cash provided by in financing activities		286,187			199,740
Net cash provided from in financing activities		39,088			280,000
Net decrease in cash		~~215~~(76,~~368~~641	)		(~~196~~192,~~559~~359	)
Cash, beginning balance		~~431~~417,~~112~~678			~~484~~431,~~427~~112
Cash, end of period	$	~~646~~341,~~480~~038			~~287~~238,~~868~~753
Supplemental disclosures of cash flow information:
Cash Paid for Interest	$	1317,~~010~~073			328,~~289~~944
Cash Paid for Income Taxes	$	-			-
Supplemental disclosure of non-cash financing activities:
Common Stock issued for payment of convertible note interest		4011,~~508~~007			2311,~~667~~007
Equipment obtained through financing	$	-		$	~~63,689~~-

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS ~~SEPTEMBER~~MARCH 3031, 2024

(UNAUDITED)

Note 1. Company Overview

Brownie’s Marine Group, Inc. (the “Company”) designs, tests, manufactures and distributes recreational hookah diving, scuba, and water safety products through its wholly owned subsidiary, Trebor Industries, Inc., a Florida corporation, incorporated in 1981 (“Trebor” or “BTL”), manufactures and sells high pressure air and industrial compressor packages, yacht based scuba air compressor and nitrox generation systems through its wholly owned subsidiary, Brownie’s High Pressure Compressor Services, Inc., a Florida corporation incorporated in 2017 (“BHP”) and doing business as LW Americas (“LWA”) and develops and markets portable battery powered surface supplied air dive systems through its wholly owned subsidiary BLU3, Inc., a Florida corporation (“BLU3”). On September 3, 2021, the Company, entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Submersible Acquisition, Inc., a Florida corporation and wholly owned subsidiary of the Company (“Acquisition Sub”), Submersible Systems, Inc., a Florida corporation (“Submersible” or “SSI”), and Summit Holdings V, LLC, a Florida limited liability company (“Summit”) and Tierra Vista Group, LLC, a Florida limited liability company (“Tierra Vista” and, together with Summit, the “Sellers”), the owners of all of the capital stock of Submersible, pursuant to which Acquisition Sub merged with and into Submersible (the “Merger”), and Submersible, the surviving corporation, became a wholly owned subsidiary of the Company.

Submersible is a manufacturer of high pressure tanks and redundant air systems for the military and recreational diving industries, based in Huntington Beach, California and sells its products to governments, militaries, private companies and the dive industry throughout the world.

On February 13, 2022 the Company filed with the Florida Department of State, the articles of incorporation for a new wholly owned subsidiary, Live Blue, Inc. (“LBI”). LBI utilizes technology developed by BLU3 to provide new users and interested divers a guided tour experience. On May 2, 2022, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Gold Coast Scuba, LLC, a Florida limited liability company (“Gold Coast Scuba”), Steven M. Gagas and William Frenier, the sole members of Gold Coast Scuba (together, the “LLC Members”) and LBI. Pursuant to the terms of the Asset Purchase Agreement, LBI acquired substantially all of Gold Coast Scuba’s assets and assumed certain non-material liabilities of the business associated with these assets. In addition, LBI assumed the lease for the premises for Gold Coast Scuba as part of this asset acquisition.

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such interim financial statements do not include all the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete annual financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The balance sheet as of December 31, ~~2023~~2024 has been derived from the Company’s annual financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2023~~2024 for a broader discussion of the Company’s business and the risks inherent in such business. The results of operations for the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending December 31, ~~2024~~2025.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Trebor, BHP, BLU3, SSI and LBI. All significant intercompany transactions and balances have been eliminated in consolidation.

Use of estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents

Only highly liquid investments with original maturities of 90 days or less are classified as cash and equivalents. These investments are stated at cost, which approximates market value.

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per EIN. At ~~September~~March 3031, ~~2024 and~~2025 and December 31, ~~2023~~2024, the Company had approximately $~~217,771~~0 and $25,000, ~~respectively,~~ in excess of the FDIC insured limit.

Accounts receivable

The Company manufactures and sells its products to a broad range of customers, primarily retail stores. Few customers are provided with payment terms of 30 days. The Company has tracked historical loss information for its trade receivables and compiled historical credit loss percentages for different aging categories (current, 1–30 days past due, 31–60 days past due, 61–90 days past due, and more than 90 days past due).

In accordance with ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), management believes that the historical loss information it has compiled is a reasonable base on which to determine expected credit losses for trade receivables held at ~~September~~March 3031, ~~2024~~2025, because the composition of the trade receivables at that date is consistent with that used in developing the historical credit-loss percentages (i.e., the similar risk characteristics of its customers and its lending practices have not changed significantly over time). As a result, management applied the applicable credit loss rates to determine the expected credit loss estimate for each aging category. Accordingly, the allowance for expected credit losses at ~~September~~March 3031, ~~2024~~2025 and December 31, ~~2023~~2025 totaled $2317,~~665~~933 and $5452,~~427~~660, respectively.

Inventory

Inventory consists of the following:

Schedule of Inventory

	September 30, 2024 (unaudited)			December 31, 2023
	March 31, 2025 (unaudited)			December 31, 2024
Raw materials	$	1,~~199~~440,~~389~~541		$	1,~~063~~397,~~888~~819
Work in process		4060,978			6340,~~258~~978
Finished goods		~~925~~873,~~049~~453			1821,~~004,160~~912
Rental Equipment		-			~~55,893~~-
Allowance excess and obsolete inventory		(198,328	)		(188,392	)
Allowance reserve		(174,419	)		(198,430	)
Inventory, net	$	12,~~967~~200,~~088~~553		$	12,~~998~~062,~~807~~279

Revenue Recognition

The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. The Company typically satisfies its performance obligations in contracts with customers upon shipment of the goods. Generally, payment is due upon receipt of the invoice and the contracts do not have significant financing components. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated based on the actual allowances given. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.

A breakdown of the total revenue between related party and non-related party revenue is as follows:

Schedule of Related Party and Non-~~Related~~related Party Revenue

	2024		2023
	2025		2024
	Nine months ended September 30
	Three months ended March 31
	2024		2023
	2025		2024
	(unaudited)		(unaudited)
Revenues	$	61,~~147~~320,~~102~~005	$	51,~~321~~492,~~577~~299
Revenues - related parties		~~318~~209,~~951~~198		~~671~~115,~~194~~223
Total Revenues	$	61,~~466~~529,~~053~~203	$	51,~~992~~607,~~771~~522

Cost of Sales

Cost of sales consists of the cost of the components of finished goods, the costs of raw materials utilized in the manufacture of products, in-bound and out- bound freight charges, direct manufacturing labor as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete ~~inventory~~products, and royalties paid on licensing agreements. Components account for the largest portion of the cost of sales. Components include plastic molded parts, gas powered engines, aluminum pressure bottles, electronic parts, batteries and packaging materials.

The breakdown of cost of sales to include cost of sales for related party and non-related party as well as the related party and non-related party royalty expense is as follows:

	2024		2023
	Nine months ended September 30
	2024		2023
	(unaudited)		(unaudited)
Cost of revenues	$	3,556,055	$	3,734,350
	Three months ended March 31
Cost of revenues - related parties		140,671		325,037
	2025		2024
Cost of revenues		140,671		325,037
	(unaudited)		(unaudited)
Royalties expense - related parties		45,073		49,264
Cost of revenues	$	923,287	$	889,918
Royalties expense		102,746		107,308
Cost of revenues - related parties		72,264		53,124
Total cost of revenues	$	3,844,545	$	4,215,959
Cost of revenues		72,264		53,124
Royalties expense - related parties		3,992		9,061
Royalties expense		25,629		67,984
Total cost of revenues	$	1,025,172	$	1,020,087

Lease Accounting

The Company accounts for leases in accordance with ASC 842, Leases.

The lease standard requires all leases to be reported on the balance sheet as right-of-use assets and lease obligations. The Company elected the practical expedients permitted under the transition guidance of the new standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company did not reassess whether any contracts entered into prior to adoption are leases or contain leases.

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company did ~~not~~ not have any finance leases as of ~~June~~March 3031, 2024. The Company’s leases generally have terms that range from three years for equipment and five to twenty years for property. The Company elected the accounting policy to include both the lease and non-lease components of its agreements as a single component and account for them as a lease.

~~Operating~~Lease ~~lease~~ liabilities are recognized at the present value of the fixed lease payments using a discount rate based on similarly secured borrowings available to the Company. ~~Operating~~Lease ~~lease right-of-use (“ROU”)~~ assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the leases. ~~Operating~~Lease ~~lease ROU~~ assets are tested for impairment in the same manner as long-lived assets used in operations. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

When the Company has the option to extend the lease term, terminate the lease for the contractual expiration date, or purchase the leased asset, and it is reasonably certain that the Company will exercise the option, it considers these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

For the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, and ~~September~~March 3031, ~~2023~~2024, cash paid for operating lease liabilities was $~~186~~60,~~290~~ 376 and $~~186~~66,~~951~~075, respectively.

Supplemental balance sheet information related to leases was as follows:

Operating Leases	~~September~~March 3031, ~~2024~~2025
	(unaudited)
Right-of-use assets	$	~~656~~1,~~202~~538,941
Current lease liabilities	$	~~161~~418,~~277~~327
Non-current lease liabilities		~~527~~1,~~502~~163,249
Total lease liabilities	$	~~688~~1,~~779~~518,576

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. ASC 718 requires companies to measure the cost of employee and non-employee services received in exchange for an award of equity instruments, including stock options, based on the grant- date fair value of the award and to recognize it as compensation expense over the period the employee and non-employee are required to provide service in exchange for the award, usually the vesting period.

The Company uses the Black-Scholes valuation model to calculate the fair value of options and warrants issued to both employees and non-employees. Stock issued for compensation is valued on the effective date of the agreement in accordance with generally accepted accounting principles, which includes determination of the fair value of the share-based transaction. The fair value is determined through use of the quoted stock price.

Derivatives

The accounting treatment of derivative financial instruments requires that the Company record certain warrants and embedded conversion options at their fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into certain note agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy, by earliest issuance date, in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors, as long as the certain variable issuance terms in certain convertible instruments exist. As of ~~September~~March 3031, ~~2024,~~2025 and ~~December~~ December 31, ~~2023~~2024, the Company did not have any derivative liabilities.

Loss per share of common stock

Basic loss per share excludes any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed ~~using~~ using the weighted- average number of outstanding common shares during the applicable period. Diluted loss per share is computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Common stock ~~equivalent~~ equivalent shares are excluded from the computation if their effect is anti-dilutive. ~~For~~At ~~the~~March ~~three months ended September 30~~31, ~~2024~~2025, ~~58,587,535 shares were included in diluted weighted average common stock outstanding~~ and ~~for~~March ~~the three months ended September 30~~31, ~~2023, 149,087,986 shares of potentially dilutive shares were not recognized as their inclusion would be anti-dilutive. For the nine months ended September 30,~~ 2024, ~~and September 30~~50, ~~2023~~808,957 ~~58,587,535 shares~~ and ~~149~~107,~~612~~761,~~199~~177 shares, respectively, of potentially dilutive shares were not recognized as their inclusion would be anti-dilutive. These shares ~~reflect~~ reflect shares potentially issuable under convertible notes, outstanding warrants, outstanding stock options and the conversion of ~~preferred~~ preferred stock.

Recent accounting pronouncements

ASU 2016-13 Current Expected Credit Loss (ASC326)

In December 2021, the FASB issued an update to ASU No. 2016-13 the Current Expected Credit Losses (CECL) standard (ASC 326), which is designed to provide greater transparency and understanding of credit risk by incorporating estimated, forward-looking data when measuring lifetime Estimated Credit Losses (ECL) and requires enhanced financial statement disclosures. This guidance was adopted on January 1, 2023, with no effect to the financial statements.

ASU 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity.

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exceptions. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements.

Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption or are not applicable.

Note 3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these consolidated financial statements ~~were issued~~. For the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, the Company incurred a net loss of $81113,~~938~~039. At ~~September~~March 3031, ~~2024~~2025, the Company had an accumulated deficit of $17,~~767~~980,~~548~~677. Despite a small working capital ~~surplus~~deficit of approximately $~~424~~6,~~805,~~ 428 at ~~September~~March 3031, ~~2024~~2025, the continued losses and cash used in operations raise substantial doubt as to the Company’s ability to continue as a going concern for the twelve months after the date the financial statements were issued. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to increase revenues, control expenses, raise capital and sustain adequate working capital to finance its operations. The failure to achieve the necessary levels of profitability and cash flows would be detrimental to the Company. The consolidated financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern.

Note 4. Related Party Transactions

The Company sells products to Brownie’s Southport Divers, Brownie’s Yacht Toys and Brownie’s Palm Beach Divers, companies owned by the brother of Robert Carmichael, the Company’s Chief Executive Officer and Chief Financial Officer. Terms of sale are no more favorable than those extended to any of the Company’s other customers with similar sales volumes. These entities accounted for 415.98% and 117.2% of the net revenues for the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025 and ~~September~~March 3031, ~~2023~~2024, respectively. Accounts receivable from these entities ~~totalled~~totaled $4619,~~372~~853.38 and $1712,~~828~~839, at ~~September~~March 3031, ~~2024~~2025 and December 31, ~~2023~~2024, respectively.

The Company sells products to ~~Brownies Global Logistics (“~~BGL”) and 940 ~~Associates (“940~~ A”), entities wholly-owned by Robert Carmichael. Terms of sale are more favorable than those extended to the Company’s regular customers, but no more favorable than those extended to the Company’s strategic partners. Accounts receivable from these entities ~~totalled~~totaled $212,~~260~~389.22 and $1410,~~302~~266 at ~~September~~ 30March 31, ~~2024~~2025 and December 31, ~~2023~~2024, respectively.

The Company had accounts payable to related parties of $5629,~~993~~365 and $4652,~~578~~173 at ~~September~~March 3031, ~~2024~~20254 and December 31, ~~2023~~2024, respectively. The ~~balance~~ balance payable at ~~September~~March 3031, ~~2024~~2025 was comprised of $4318,~~096~~889due ~~due~~ to ~~940 A, $3,897 due to~~ Robert Carmichael and $10,~~000~~476 due to Blake Carmichael. At December 31, ~~2023~~2024, the balance payable was comprised of $2923,~~559~~713 due to 940 A, $~~12,019~~460 due to Robert Carmichael and $510,000 due to Blake Carmichael.

The Company has exclusive license agreements with 940 A to license the trademark “Brownie’s Third Lung”, “Tankfill”, “Brownie’s Public Safety” and various other related trademarks as listed in the agreements. The agreements provide that the Company pay 2.5% of gross revenues per quarter as a royalty to 940A. Total royalty fees paid to 940A for the three months ended ~~September~~March 3031, ~~2024~~2025 and ~~September~~March 3031, ~~2023~~2024 was $243,~~021~~992 and $319,~~335~~061, respectively. The accrued royalty for ~~September~~March 3031, ~~2024~~2025 and December 31, ~~2023~~2024 was $24,~~155~~290 and $27,~~238~~385 which is included in other liabilities.

On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day value weighted average price (“VWAP”) of the Company’s stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $0.021 per share at any time. The conversion rate was calculated at a 35% discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $19,250 for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. ~~There were payments totaling $3,047 made with products in kind during the three months ended September 30, 2024~~. The outstanding balance on this note was $5739,~~296~~088 as of ~~September~~March 3031, ~~2024~~ 2025.

On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, a Company director, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year warrant to purchase one share of common stock at an exercise price of $0.0175 per share in consideration of $200,000.

On September 14, 2023, the Company issued a convertible demand 8% promissory note in the principal amount of $50,000 to Robert Carmichael ~~for~~ for funds to meet the working capital needs of BLU3. There is no amortization schedule for the note, ~~and~~as ~~interest is payable in shares of common stock of~~ the ~~Company~~note atis ~~a conversion price equal to the 90 day VWAP of the Company’s stock prior to the quarterly~~ interest ~~payment~~ ~~date~~free. ~~The note holder may demand payment or convert the outstanding principal at a conversion rate of $0~~.~~01351~~ ~~per share at any time.~~ The ~~conversion rate was calculated at a 35% discount to the 90 day VWAP of the~~ Company~~’s stock as of the date of the note.~~ ~~The Company~~ recorded $-0- for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $50,000 as of ~~September~~March 3031, ~~2024~~2025.

On November 714, 2023, the Company borrowed funds through the issuance of a promissory note (the Note) in the principal amount of $150,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The maturity date of the Note ~~was~~is May 7, 2024 (the “Maturity Date”). The ~~note~~Note bears interest at a rate of 9.9% per annum, and ~~has~~ a default interest ~~rate~~ of 18% per annum. Interest payments ~~are~~shall be due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty. ~~The balance of $150,000 was outstanding as of September 30, 2024, and the maturity date was extended to May 7, 2025, pursuant to an amendment dated November 13, 2024.~~

On February 5, 2024, the Company borrowed funds through the issuance of a promissory note (the Note) in the principal amount of $280,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The maturity date of the ~~note~~Note ~~was~~ is August 6, 2024 (the “Maturity Date”). The ~~note~~Note bears interest at a rate of 9.9% per annum, and ~~has~~ a default interest ~~rate~~ of 18% per annum. Interest payments ~~are~~shall be due and payable on a monthly basis. The Company may prepay the ~~note~~Note in whole or in part, at any time without premium or penalty. ~~The balance of $280,000 was outstanding as of September 30, 2024, and the due date was extended to a due date of May 5, 2025, pursuant to an amendment dated November 13, 2024.~~

On March 31, 2023, the Company issued 61,~~677~~204 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2023. The fair value of these shares was $1,336.

On June 30, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2023. The fair value of these shares was $1,287.

On September 30, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending September 30, 2023. The fair value of these shares was $1,287.

On December 31, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending December 31, 2023. The fair value of these shares was $1,287.

On March 31, 2024, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2024. The fair value of these shares was $41,~~007~~287.

On ~~June~~July 3016, 2024, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2024. The fair value of these shares was $1,~~336~~287.

On ~~September~~August 3015, 2024, the Company issued 61850,~~677~~000 shares ~~of common stock~~ to ~~Robert~~Davis ~~Carmichael~~Natan ~~for~~per ~~payment~~a ofconsulting ~~interest on the convertible demand note for the three months ending September 30, 2024~~agreement. The fair value of these shares was $18,~~336~~500.

On December 9, 2024, the Company issued 8,241,759 shares of common stock to Blake Carmichael as compensation for a reduction in salary. The fair value of these shares was $60,000..

Note 5. Convertible Promissory Notes and Loans Payable

Convertible Promissory Notes

Convertible promissory notes consisted of the following at ~~September~~March 3031, ~~2024~~2025:

Origination Date	Maturity Date	Interest Rate			Origination Principal Balance		Original Discount Balance			Period End Principal Balance		Period End Discount Balance			Period End Balance, Net		Accrued Interest Balance		Reg.
9/03/21	9/03/24		8	%		346,500		(12,355	)	$	346,500	$	-854	)	$	~~346~~347,~~500~~354		-		(1	)
9/03/21	9/03/24		8	%		3,500		(125	)		3,500		-14	)		3,~~500~~514		-		(2	)
9/30/22	Demand		8	%		66,793		(19,~~245~~250	)		6358,~~746~~338		(619,~~450~~250	)		5739,~~296~~088		-		(3	)
										$	413,746	$	(6,450	)	$	407,296	$	-
09/14/23	Demand		8	%							50,000					50,000				(4	)
										$	458,338	$	(18,382	)	$	439,956	$	-

(1) On September 3, 2021, the Company issued a three-year 8% convertible promissory note in the principal amount of $346,500 to Summit Holding V, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in shares of common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 per share at any time during the term of the note. The Company recorded $12,355 for the beneficial conversion feature. This note is classified as a current liability for the ~~three~~quarter ~~months~~ ended March 31, 2025. The maturity due date of the note has been extended by the lender from September 303, 2024 to ______________ while the Company works through a determines a restructure of the note.

(2) On September 3, 2021, the Company issued a three-year 8% promissory note in the principal amount of $3,500 to Tierra Vista Partners, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 at any time during the term of the note. The Company recorded $125 for the beneficial conversion feature. This note is classified as a current liability for the ~~three~~quarter ~~months~~ ended ~~September~~March 3031, 2024.

(3) On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day VWAP of the Company’s stock prior to the quarterly interest payment date. This note is classified as a current liability as the note holder may demand payment or convert the outstanding principal at a conversion price of $0.021 per share at any time. The Company recorded $19,250 for the beneficial conversion feature. ~~This note is classified as a current liability for the three months ended September 30, 2024.~~

(4) On September 14, 2023, the Company issued a convertible demand 8% promissory note in the principal amount of $50,000 to Robert Carmichael for working capital needs of BLU3. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day (“VWAP”) of the Company’s common stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $0.01351 per share at any time. The conversion rate was calculated at a 35% discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $-0- for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $50,000 as of December 31, 2024 and December 31, 2023. Mr. Carmichael has waived interest payments on this note effective September 14, 2023.

A breakdown of current and long-term amounts due are as follows for the convertible promissory notes as of ~~September~~March 3031, ~~2024~~2025:

	Summit Holdings V, LLC Note			Tierra Vista Partners, LLC Note			Robert Carmichael Note			Total
	Summit Holdings V,			Tierra Vista Partners,			Robert Carmichael			Robert Carmichael
2024		346,500			3,500			63,746			413,746
	LLC Note			LLC Note			LBI Note			BLU3 Note			Total
Discount		-			-			(6,450	)		(6,450	)
2025	$	346,500		$	3,500		$	58,338		$	50,000		$	458,338
Total Loan Payments	$	346,500		$	3,500		$	57,296		$	407,296
Discount		854	)		14	)		(19,250	)		( -	)		(18,382	)
Current Portion of Loan Payable	$	(346,500	)	$	(3,500	)	$	(57,296	)	$	(407,296	)
Total Loan Payments	$	347,354		$	3,514		$	39,088		$	50,000		$	439,956
Non-Current Portion of Loan Payable	$	-		$	-		$	-		$	-
Current Portion of Loan Payable	$	(347,354	)	$	(3,514	)	$	(39,088	)	$	(50,000	)	$	(439,956	)
Non-Current Portion of Loan Payable	$	-		$	-		$	-		$	-		$	-

	Payment Amortization
2024		346,500
2025		346,500
Total Note Payments	$	~~346,500~~-
Current portion of note payable		(346,500	)
Non-Current Portion of Notes Payable	$	-

(2)

On September 3, 2021, the Company issued a three-year 8% promissory note in the principal amount of $3,500 to Tierra Vista Partners, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 at any time during the term of the note. The Company recorded $125 for the beneficial conversion feature. This note is classified as a current liability for the quarter ended March 31, 2024.

	~~Payment Amortization~~	Payment Amortization
2024		3,500
2025		3,500
Total Note Payments	$	~~3,500~~-
Current portion of note payable		(3,500	)
Non-Current Portion of Notes Payable	$	-

(3) On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day VWAP of the Company’s stock prior to the quarterly interest payment date. This note is classified as a current liability as the note holder may demand payment or convert the outstanding principal at a conversion price of $0.021 per share at any time. The Company recorded $19,250 for the beneficial conversion feature. This note is classified as a current liability for the three months ended September 30, 2024.

(3)	On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day VWAP of the Company’s stock prior to the quarterly interest payment date. This note is classified as a current liability as the note holder may demand payment or convert the outstanding principal at a conversion price of $0.021 per share at any time. The Company recorded $19,250 for the beneficial conversion feature.

(4)	On September 14, 2023, the Company issued a convertible demand 8% promissory note in the principal amount of $50,000 to Robert Carmichael for working capital needs of BLU3. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day (“VWAP”) of the Company’s common stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $0.01351 per share at any time. The conversion rate was calculated at a 35% discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $-0- for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $50,000 as of December 31, 2024 and December 31, 2023. Mr. Carmichael has waived interest payments on this note effective September 14, 2023.

	Demand Notes

	On November 14, 2023, the Company issued a promissory note in the principal amount of $150,000 to Charles Hyatt, a director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The maturity date of the Note is May 7, 2024 (the “Maturity Date”). The Note bears interest at a rate of 9.9% per annum, and a default interest of 18% per annum. Interest payments shall be due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty. The balance of $280,000 was outstanding as of December 31, 2024, and the due date was extended to a due date of May 5, 2025, pursuant to an amendment dated November 13, 2024.

	On February 5, 2024, the Company borrowed funds through the issuance of a promissory note in the principal amount of $280,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The maturity date of the note was August 6, 2024. The note bears interest at a rate of 9.9% per annum, and has a default interest rate of 18% per annum. Interest payments are and payable on a monthly basis. The Company may prepay the note in whole or in part, at any time without premium or penalty. The balance of $280,000 was outstanding as of December, and the due date was extended to a due date of May 5, 2025, pursuant to an amendment dated November 13, 2024

Loans Payable

	Mercedes BMG (1)				Navitas BLU3 (2)				NFS SSI (3)				Navitas 2022 BLU3 (4)				Navitas 2024 BLU3 (5)				Navitas 2024 BLU3 (6)				Total
		Mercedes BTL (1)				Navitas 2021 BLU3 (2)				NFS SSI (3)				Navitas 2022 BLU3 (4)				Navitas 2024 BLU3 (5)				Navitas 2024 BTL (6)				Total
2024 (6 months)	$	2,792			$	7,782			$	6,991			$	14,342			$	1,713			$	898			$	34,518
							-				-				-												-
2025		~~8,376~~	5,584			~~19,556~~	21,432			~~12,329~~	4,555			~~25,143~~	17,941			~~5,604~~	4,223			~~3,890~~	2,963			~~74,897~~	56,697
2026		-	-			~~6,339~~	6,338			-	-			-	-			~~6,304~~	6,243			~~4,411~~	4,411			~~17,054~~	16,691
2027		-	-				-			-	-			-	-			~~7,092~~	7,022			~~5,002~~	5,002			~~12,093~~	12,024
Thereafter		-				-				-				-				8,685				10,419				19,105
2028			-				-				-				-				7,899				5,672				13,571
Total Loan Payments	$	11,168			$	33,667			$	19,320			$	39,485			$	29,398				24,620			$	157,668
Thereafter			-				-				-				-				1,409				4,747				6,157
Current Portion of Loan Payable	$	(11,168	)		$	(17,665	)		$	(19,320	)		$	(22,991	)		$	(5,442	)			(3,809	)		$	(80,395	)
Total Loan Payments			5,584				27,770				4,555				17,941				26,796				22,794				105,440
Non-Current Portion of Loan Payable	$	-			$	16,012			$	-			$	16,494			$	23,957				20,811			$	77,273
Current Portion of Loan Payable			(5,584	)			(21,432	)			(4,555	)			(17,941	)			(5,771	)			(4,014	)			(59,298	)
Non-Current Portion of Loan Payable			-				6,338				-				-				21,025				18,780				46,143

(1)	On August 21, 2020, the Company executed an installment sales contract with Mercedes Benz Coconut Creek for the purchase of a 2019 Mercedes Benz Sprinter delivery van. The installment agreement is for $55,841 with a zero interest rate payable over 60 months with a monthly payment of $931 and is personally guaranteed by Mr. Carmichael. The loan balance as of ~~September~~March 3031, 2024 was $1117,~~168~~063 and $19,855 as of December 31, 2023.
(2)	On May 19, 2021, BLU3 executed an equipment finance agreement with Navitas Credit Corp. (“Navitas”) to finance the purchase of certain plastic molding equipment. The amount financed is $75,764 payable over 60 equal monthly installments of $1,611. The equipment finance agreement contains customary events of default. The loan balance as of ~~September~~March 3031, 2024 was $3338,~~667~~492 and $42,525 as of December 31, 2023.
(3)	On June 29, 2022, SSI executed an equipment financing agreement with NFS Leasing (“NFS Leasing”) to secure replacement production molds. The total purchase price of the molds was $84,500 of which $63,375 was financed by NFS Leasing on August 15, 2022. The financing agreement has a 33 month term beginning in August 2022 with a monthly payment of $2,571. The financing agreement contains customary events of default, is guaranteed by the Company and NFS Leasing has a lien on all of the assets of SSI. The loan balance as of ~~September~~March 3031, 2024 and December 31, 2023 was $1932,~~320~~448 and $38,607, respectively.
(4)	On December 12, 2022, BLU3 executed an equipment finance agreement to finance the purchase of certain plastic molding equipment through Navitas. The amount financed is $63,689 payable over 36 equal monthly installments of $2,083. The equipment finance agreement contains customary events of default. The loan balance as of ~~September~~March 3031, 2024 was $~~439~~41,~~485~~273 and $44,839 as of December 31, 2023.
(5)	On February 12, 2024, BLU3 executed an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $32,274 payable over 60 equal monthly installments of $715. The inventory finance agreement contains customary events of default. The loan balance as of ~~September~~March 3031, 2024 was $2931,~~398~~476.
(6)	On September 4, 2024, BLU3 executed an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $24,620 payable over 60 equal monthly installments of $602. The inventory finance agreement contains customary events of default. The loan balance as of September 30, 2024 was $24,620.

1615

(6)

On September 4, 2024, BLU3 executed an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $24,620 payable over 60 equal monthly installments of $602. The inventory finance agreement contains customary events of default. The loan balance as of September 30, 2024 was $23,722.

Note 6. Goodwill and Intangible Assets, Net

The following table sets for the changes in the carrying amount of the Company’s Goodwill for the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025.

Summary of Changes in Goodwill

	2024
	2025
Balance, January 1	$	249,986
Addition:		-
Balance, September 30	$	249,986
Balance, March 31	$	249,986

The Company performed an evaluation of the value of goodwill at December 31, 2023. Based upon this evaluation it was determined that there should be no adjustment to goodwill. There has been nothing noted during the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025 that would indicate ~~that~~ that the value of goodwill should change through that date.

The following table sets for the components of the Company’s intangible assets at ~~September~~March 3031, ~~2024~~2025:

Summary of Intangible Assets

	Amortization Period (Years)		Cost		Accumulated Amortization			Net Book Value
Intangible Assets Subject to amortization
Trademarks		15	$	121,000	$	(2426,~~828~~785	)	$	9694,~~172~~215
Customer Relationships		10		600,000		(~~185~~205,000	)		~~415~~395,000
Non-Compete Agreements		5		22,000		(1315,~~567~~766	)		86,~~433~~234
Total			$	743,000	$	(~~223~~247,~~395~~551	)	$	~~519~~495,~~605~~449

The aggregate amortization remaining on the intangible assets as of ~~September~~March 3031, ~~2024~~2025 is a follows:

	Intangible Assets Amortization
	Intangible Amortization
2024 (3 months remaining)		18,116
2025 (9 months remaining)		66,426
2025		7271,~~467~~367
2026		71,367
2027		68,~~066~~067
2028		68,~~066~~067
Thereafter		221,523
Total	$	~~519~~495,~~605~~449

Amortization expense for amortizable intangible assets for each of the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025 and ~~2023~~2024 was ~~$54~~18,~~350~~117.

Note 7. Stockholders’ Equity

Common Stock

On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year warrant to purchase one share of common stock at an exercise price of $0.0175 per share in consideration of $200,000.

On March 31, 2023, the Company issued 61,204 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2023. The fair value of these shares was $1,336.

On March 31, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2022. The fair value of these shares was $7,000.

On June 30, 2023, the Company issued 61,205 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2023. The fair value of these shares was $1,326.

On June 30, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2023. The fair value of these shares was $7,000.

On September 30, 2023, the Company issued 61,205 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending September 30, 2023. The fair value of these shares was $1,326.

On September 30, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending September 30, 2023. The fair value of these shares was $7,000.

On December 31, 2023, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2023. The fair value of these shares was $7,000.

On March 31, 2024, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending ~~March~~December 31, ~~2024~~2023. The fair value of these shares was $41,~~007~~287.

On March 31, 2024, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending ~~March~~December 31, ~~2024~~2023. The fair value of these shares was $7,000.

On June 30, 2024, the Company issued 123,354 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2024. The fair value of these shares was $2,672.

On June 30, 2024, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2024. The fair value of these shares was $4,328.

On August 15, 2024 the Company issued 850,000 shares of common stock to the holders of convertible notes for payment of professional services. The fair market value of these shares was $8,500.

On September 30, 2024, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending September 30, 2024. The fair value of these shares was $7,000.

On December 9, 2024, the Company issued 8,241,759 shares to Blake Carmichael as compensation related to a salary reduction. The fair market value of these shares was $60,000.

On December 31, 2024, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2024. The fair value of these

shares was $7,000.

On March 31,2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31 2025,. The fair value of these shares was $7,000.

Preferred Stock

During the second quarter of 2010, the holders of the majority of the Company’s outstanding shares of common stock approved an amendment to the Company’s Articles of Incorporation authorizing the issuance of 10,000,000 shares of blank check preferred stock. The blank check preferred stock as authorized has such voting powers, designations, preferences, limitations, restrictions and relative rights as may be determined by the Board of Directors of the Company from time to time in accordance with the provisions of the Florida Business Corporation Act. In April 2011, the Board of Directors designated 425,000 shares as Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is convertible into a share of the Company’s common stock at any time at the option of the holder at a conversion price of $18.23 per share. Holders of shares of Series A Convertible Preferred Stock are entitled to 250 votes for each share held. The Company’s common stock and Series A Convertible Preferred Stock vote together on any matters submitted to our shareholders. As of ~~September~~March 3031, ~~2024~~2025, and December 31, ~~2023~~2024, 425,000 shares of Series A Convertible Preferred Stock are issued ~~and~~ and outstanding and are owned by Robert Carmichael.

1817

Equity Incentive Plan

On May 26, 2021 the Company adopted an Equity Incentive Plan (the “Plan”). Under the Plan, stock options may be granted to employees, directors, and consultants in the form of incentive stock options or non-qualified stock options, stock purchase rights, time vested and/performance invested restricted stock, and stock appreciation rights and unrestricted shares may also be granted under the Plan. 25,000,000 shares are reserved for issuance under the Plan. The term of the Plan is ten years.

The Company also issued options outside of the Plan that were not approved by the security holders. These options may be granted to employees, directors, and consultants in the form of incentive stock options or non-qualified stock options.

Equity Compensation Plan Information as of ~~September~~March 3031, ~~2024~~2025:

Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)

Weighted – average exercise price of outstanding options, warrants and rights (b)

Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) (c)

Equity Compensation Plans Approved by Security Holders

31,~~150~~800,000

0.~~0399~~04474

2123,~~680~~200,~~882~~000

Equity Compensation Plans Not Approved by Security Holders

28,869,400

0.0432

—

Total

3230,~~019~~669,400

0.~~0428~~0432

2123,~~680~~200,~~882~~000

Options

~~The~~For ~~Company~~the ~~has~~years ~~issued~~ended ~~options~~December to31, ~~purchase~~2024 ~~approximately~~and 322023,~~019,400~~ ~~shares~~the ofCompany ~~its~~has ~~common~~issued ~~stock~~no atoptions. anUpon ~~weighted average~~ exercise, ~~price~~shares of ~~$0.0428 with~~new acommon ~~fair~~stock ~~value~~are ofissued ~~approximately $37,000. For~~ by the ~~three months ended September 30, 2024, and the year ended December 31, 2023, the~~ Company ~~issued no options to purchase shares~~.

For the ~~nine~~years ~~months~~ ended ~~September~~December 3031, 2024 and 2023, the Company recognized an expense of approximately $1291,~~423~~492 and $2581,~~404~~424, respectively, of non-cash compensation expense (included in General and Administrative expense in the accompanying Consolidated Statement of Operations) ~~determined~~ determined by application of a Black-Scholes option pricing model with the following inputs: exercise price, dividend yields, risk-free ~~interest~~ interest rate, and expected annual volatility. As of September 30, 2024, the Company had $1,066,753 of unrecognized pre-tax non-cash compensation expense related to performance based options to purchase shares, which the Company expects to recognize, based on a weighted-average period of 1.5 years. The Company uses straight-line amortization of compensation expense over the requisite service period for time-based options. For performance-based options the Company evaluates the likelihood of a vesting qualification being met, and will establish the expense based on that evaluation. The maximum contractual term of the Company’s stock options is 5 years. The Company recognizes forfeitures ~~and expirations~~ as they occur. ~~Options~~There are options to purchase 42approximately 5,~~198~~806,~~387~~266 shares ofthat ~~common stock~~ have vested as of ~~September~~December 3031, 2024.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

	Nine Months ended September 30,
	Year ended December 31,
	2024			2023
	2025			2024
Expected volatility		~~172~~266.0% - 346.4 %	%		172.0% – 346.4 %	%
Expected term		1.5 – 5.0 Years			1.5- – 5.0 Years
Risk-free interest rate		0.1621% - 43.6418 %	%		0.16% - 4.64 %	%
Forfeiture rate		0.33	%		0.17	%
Forfeiture Rate		2.2	%		0.17	%

The expected volatility was determined with reference to the historical volatility of the Company’s ~~common~~ stock. The Company uses ~~historical~~ historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted ~~represents~~ represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the ~~contractual~~ contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.

~~A summary of the status of the Company’s outstanding stock options as of September 30, 2024 and December 31, 2023 and changes during the periods ending on such dates is as follows:~~18

A summary of the status of the Company’s outstanding stock options as of December 31, 2025 and 2024 and changes during the periods ending on that date is as follows

	Year ended December 31,
	2025			2024
Expected volatility		266.0% - 346.4 %			172.0% – 346.4 %
Expected term		1.5 – 5.0 Years			1.5- 5.0 Years
Risk-free interest rate		0.21% - 3.18 %			0.16% - 4.64 %
Forfeiture Rate		2.2	%		0.17	%

The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.

A summary of the status of the Company’s outstanding stock options as of December 31, 2025 and 2024 and changes during the periods ending on that date is as follows

	Number of			Weighted Average Exercise		Weighted Average Remaining Contractual		Aggregate Intrinsic
						Weighted
	Weighted					Average
	Average					Remaining		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Options			Price		Life in Years		Value
Outstanding at December 31, 2022		238,439,167		$	0.0362		1.43
Granted		-			-
Forfeited		(170,999,530	)		0.0379
Exercised		-			-
Expired		(35,295,237	)		0.0180
Cancelled		-			-
Outstanding – December 31, 2023		67,439,637		$	0.~~0360~~0362		1.43
Exercisable – December 31, 2023		41,057,753		$	0.~~0211~~0321		01.8133	$	-68,994
Granted		-			-
Forfeited		35(1,~~420~~475,~~237~~000	)		0.~~0181~~0379
Exercised		-			-
Expired		(35,295,237	)		0.0180
Cancelled		-			-
Outstanding – September 30, 2024		32,019,400		$	0.0428		1.75
Outstanding – December 31, 2024		30,669,400		$	0.0432		1.68
Exercisable – September 30, 2024		14,019,400		$	0.0216		0.37	$	-
Exercisable – December 31, 2024		5,806,266		$	0.0448		2.01	$	-
Exercisable – March 31, 2025		0			0		0		0

The following table summarizes information about employee stock options outstanding at ~~September~~December 3031, 2024.

~~Summary~~ Schedule of Exercise Price of Employee Stock Options Outstanding

Range of Exercise Price	Number outstanding at ~~June~~December 3031, 2024		Weighted average remaining ~~Life~~life		Weighted average exercise price		Number exercisable at ~~June~~December 3031, 2024		Weighted average exercise price		Weighted average remaining life
$ 0.0229 - $0.0325		150,~~050,~~000		1.6462	$	0.~~0324~~0302		150,~~050,~~000	$	0.~~0324~~0302		1.6462
$ 0.0360 - $0.0425		2322,~~009~~659,400		1.7955	$	0.0398		54,~~009~~659,400	$	0.~~0393~~0395		1.6142
$ 0.0440 - $0.0531		7,960,000		1.8560	$	0.~~0531~~0530		72,~~960~~350,000	$	0.~~0531~~0530		1.8544
Outstanding options		3230,~~019~~669,400		1.8068	$	0.~~0428~~0360		145,~~019~~806,~~400~~266	$	0.~~0466~~0448		12.7501

AtAs ~~September~~of 30December 31, 2024, ~~there~~the ~~was~~Company had approximately $1987,~~066,753~~ 800 of unrecognized ~~stock~~pre-tax ~~option~~non-cash compensation expense ~~which~~related to ~~may~~options beto ~~recognized~~performance ~~only~~based ifoptions to purchase shares, which the ~~full~~Company ~~vesting~~expects ~~requirements~~to recognize, based on a weighted-average period of 2.1 years. The Company uses straight-line amortization of compensation expense over the requisite service period for ~~these~~time-based options. ~~are~~For performance-based options the Company evaluates the likelihood of a vesting qualification being met, and will establish the expense based on that evaluation. Stock option expense recognized during the year ended March 31, 2025 and December 31, 2024 was $0.00 and $91,492, respectively.

~~At September 30, 2024, there was $69,001 of total unrecognized stock option expense, which is expected to be recognized on a straight-line basis over a weighted-average period of 0.45 years.~~19

Warrants

On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year ~~common stock purchase~~ warrant to purchase one share of common stock at an exercise price of $0.0175 per share in consideration of $200,000.

A summary of the Company’s warrants as of December 31, 2024 and 2023, and changes during the ~~nine~~years ~~months~~ ended ~~September~~December 3031, 2024 and 2023 is presented below:

Schedule of ~~Warrants~~Warrant Activity

	Number of			Weighted Average Exercise		Weighted Average Remaining Contractual		Aggregate Intrinsic
						Weighted
				Weighted		Average
				Average		Remaining		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Warrants			Price		Life in Years		Value
Outstanding – December 31, 2023		25,684,521		$	0.0247		0.93	$	24,000
Outstanding at December 31, 2023		18,255,951		$	.0245		1.55
Granted		-11,428,570			0.0175
Exercised		-
Forfeited		(4,000,000	)		-
Forfeited or Expired		8,541,666			0.0240
Exercised		-			-
Outstanding – September 30, 2024		17,142,858		$	0.0250		0.30
Cancelled		-			-
Exercisable – September 30, 2024		17,142,858		$	0.0250		0.30	$	-
Outstanding – December 31, 2024		25,684,521		$	0.0247		1.55
Exercisable – December 31, 2024		25,684,521		$	0.0247		1.55	$	12,000
Granted		-			-
Forfeited		(14,255,952	)		-
Exercised		-			-
Cancelled		-			-
Outstanding – December 31, 2024		11,428,570		$	0.0175		0.09
Exercisable – December 31, 2024		11,428,570		$	0.0175		0.09	$	-

~~Note 8.~~These ~~Commitments~~warrants ~~and~~expired ~~contingencies~~as of February 2025.

~~Royalty~~Note ~~Agreement~~14. Income Taxes

OnThe ~~June~~Company ~~30,~~records ~~2020,~~a ~~the~~valuation ~~Company~~allowance ~~entered~~to ~~into~~reduce ~~Amendment~~its ~~No.~~deferred 2tax assets to ~~its~~the ~~Patent~~amount ~~License~~that ~~Agreement~~is ~~with~~more ~~Setaysha~~likely ~~Technical~~than ~~Solutions,~~not ~~LLC~~to ~~(“STS”)~~be realized. While ~~The~~the ~~Amendment,~~Company ~~among~~has ~~other~~considered ~~things,~~future ~~provides~~taxable ~~that~~income ~~STS~~and ~~provide~~ongoing 30prudent ~~hours~~and ~~per~~feasible ~~week~~tax ofplanning ~~commercialization~~strategies ~~support~~in ~~for~~assessing ~~its~~the ~~NextGen~~need ~~licensed~~for the ~~products~~valuation ~~without~~allowance, ~~charge.~~in Inthe ~~consideration~~event ~~therefor,~~ the Company ~~agreed~~were to andetermine ~~increased~~that ~~minimum~~it ~~yearly~~would ~~royalty~~not ~~payment~~be able to realize all or part of ~~$60,000~~its ~~for~~net deferred ~~years~~tax ~~2022,~~assets ~~2023~~in ~~and~~the ~~2024~~future, ~~with~~an aadjustment ~~yearly~~to ~~fourth~~the ~~quarter~~deferred ~~reconciliation~~tax ~~with~~assets ~~earned~~would ~~royalties.~~be Incharged ~~addition,~~to ifincome ~~the~~in ~~Company terminates~~ the ~~Agreement~~period ~~with~~such ~~STS~~determination ~~prior~~was ~~to December 31~~made. Likewise, ~~2023,~~should the Company isdetermine ~~obligated~~that toit ~~pay~~would ~~STS~~be ~~$180,000,~~able ~~less~~to ~~cumulative~~realize ~~royalties~~its ~~paid~~deferred intax ~~excess of~~assets ~~$334,961~~in ~~for~~ the ~~years~~future ~~2019~~in ~~through~~excess ~~2024.~~of ~~Royalty~~its net recorded amount, ~~under~~an ~~the~~adjustment ~~Amendment~~to ~~was~~the ~~$102,746~~deferred ~~and~~tax ~~$107,308~~assets ~~for~~would ~~the~~increase ~~nine~~income ~~months~~in ~~ended September~~the ~~30,~~period ~~2024~~such ~~and~~determination ~~2023,~~was ~~respectively~~made.

The components of the provision for income tax expense are as follows for the years ended:

	2024			2023
	December 31,
	2024			2023
Current taxes
Federal	$	—		$	—
State		—			—
Current taxes		—			—
Change in deferred taxes		62,146			347,400
Change in valuation allowance		(62,146	)		(347,400	)

Provision for income tax expense	$	—		$	—

The following is a summary of the significant components of the Company’s deferred tax assets and liabilities at December 31, 2024 and 2023:

	2024			2023
	December 31,
	2024			2023
Deferred tax assets:
Equity based compensation	$	416,237		$	416,237
Allowance for doubtful accounts		5,954			13,800
Deferred Rent		(1,796	)		-
Reserves for slow moving inventory		50,292			47,800
Depreciation		52,867			23,800
Reserve for recall		0			3,200
Net operating loss carry forward		2,027,000			2,027,000
Total deferred tax assets		2,550,554			2,531,837
Deferred tax liabilities
Reserve for recall		-			-
Total deferred tax asset (liability)		-			-
Total deferred tax		2,550,554			2,531,837
Valuation allowance		(2,550,554	)		(2,531,837	)

Deferred tax assets, net of valuation allowance	$	-		$	-

The effective tax rate used for calculation of the deferred taxes as of December 31, 2024 was 26.35. The Company has established a 100% valuation allowance against deferred tax assets of approximately $2,550,500, due to the uncertainty regarding realization reserve against the deferred tax assets. The change in valuation allowance was an increase of $18,717. The Company has approximately $3,346,650 of net loss carryforward that expire through 2037 and $4,497,364 that carryforward indefinitely but is limited to 80% of taxable income in any one year.

The effective tax rate used for calculation of the deferred taxes as of December 31, 2023 was 21.39%. The Company has established a 100% valuation allowance against deferred tax assets of $2,531,800 due to the uncertainty regarding realization reserve against the deferred tax assets. The change in valuation allowance was an increase of $347,400.

The significant differences between the statutory tax rate and the effective tax rates for the Company for the years ended are as follows:

	December 31,
	2024			2023
Statutory tax rate		(21.00	)%		(21.00	)%
State tax, net of Federal benefits		(4.28	)%		(4.28	)%
Permanent differences		0.11	%		0.21	%
Temporary differences		(1.18	)%		3.68	%
Change in valuation allowance		26.35	%		21.39	%
Effective tax rate		—	%		—	%

The Company’s income tax returns for 2020 through 2024 remain subject to examination by the Internal Revenue Services and state tax authorities.

Note 15. Commitments and Contingencies

Leases

On August 14, 2014, the Company entered into a thirty-seven 37 month lease for its facilities in Pompano Beach, Florida, commencing on September 1, 2014. Terms included payment of a $5,367 security deposit; base rent of approximately $4,000 per month over the term of the lease plus sales tax; and payment of 10.76% of annual operating expenses (common areas maintenance), which was approximately $2,000 per month subject to periodic adjustment. On December 1, 2016, the Company entered into an amendment to the initial lease agreement, commencing on October 1, 2017, extending the term of the lease for an additional eighty-four months, expiring September 30, 2024. The base rent was increased to $4,626 per month with a 3% annual escalation throughout the amended term.

On January 4, 2018, the Company entered into a sixty-one month 61 lease renewal for its facility in Huntington Beach, California commencing on February 1, 2018. Terms included base rent of approximately $9,300 per month for the first 12 months with an annual escalation clause of 2.5% thereafter. The Company paid a security deposit of $8,450 upon entering into the lease. The Company did not renew this lease at expiration.

On November 11, 2018, the Company entered a sixty-nine month 69 lease commencing on January 1, 2019 for approximately 8,025 square feet adjoining its existing facility in Pompano Beach, Florida. Terms of the new lease include a $6,527 security deposit; initial base rent of approximately $4,848 per month escalating at 3% per year during the term of the lease plus Florida state sales tax and 10.11% of the buildings annual operating expenses (common area maintenance) which is approximately $1,679 per month, subject to adjustment as provided in the lease. The Company did not renew this lease at expiration.

On May 2, 2022, LBI entered into a lease assignment agreement with Gold Coast Scuba, LLC and Vicnsons Realty Group, LLC whereby LBI is the assignee to the remainder of the lease for the property located at 259 Commercial Blvd., Suites 2 and 3 in Lauderdale-By-The Sea, Florida. The lease is in its third year of a three-year term and has a $2,816 per month base rent. The lease provides an option to renew for an additional term of two years with an increase of base rent by 3.5%.

On September 14, 2022, SSI entered into a sixty-month lease renewal for its facility in Huntington Beach, California effective February 1, 2022. Terms included base rent of approximately $17,550 per month for the first 24 months with an annual escalation clause of 3.0% thereafter. Obligations under the lease are guaranteed by the Company. The Company paid an additional security deposit of $10,727 upon entering into the lease.

On September 30, 2022, SSI entered into a sublease of its facility in Huntington Beach, California with Camburg Engineering, Inc.(“Tenant”) commencing October 1, 2022, The term of the sublease is through December 31, 2023 with a base monthly rent of $2,247 for the first twelve months with an 3% annual escalation thereafter. The Tenant also pays a monthly common area maintenance of $112. The Tenant provided a security deposit of $2,426 upon entering into the sublease. This lease has expired but the tenant remains on a month to month basis.

On November 1, 2024, the Brownies Marine Group entered a 45 month sublease agreement with Inovar Packaging , LLC for approximately 19,065 square feet in the building located at 4061 SW , 47^th Ave, Davie, Florida, 33314. The monthly base rent staring the first of November, 2024 will be $26,000 ( twenty six thousand dollars ). The rent will increase to $31,000 ( thirty one thousand dollars ) on October 2025 through the rest of the term of tem of the lease. The sublease will terminate on July 31, 2028.

Royalty Agreement

On June 30, 2020, the Company entered into Amendment No. 2 to its Patent License Agreement with Setaysha Technical Solutions, LLC (“STS”). The amendment set certain limits and expectations of the assistance from STS related to designing and commercializing certain diving products and revised the royalty payments due to STS as consideration for uncompensated services. The Company is obligated to pay STS a minimum yearly royalty of $60,000, or $15,000 per fiscal quarter, beginning in December 2019 and increasing by 2.15% per year. The minimum royalty was temporarily increased to $60,000 for fiscal years 2022, 2023 and 2024, with a fourth quarter true up against earned royalties. In addition, if the Company terminates the Agreement with STS prior to December 31, 2023, the Company is obligated to pay STS $180,000, less cumulative royalties paid in excess of $200,174 for the years 2019 through 2024. In accordance with the amendment, the Company will pay additional minimum royalties of $60,000 per year or $15,000 per quarter for the years 2022 through 2024. On January 24, 2024, the Company entered into Addendum No. 3 to the STS Agreement. Addendum No. 3 delays the additional minimum yearly royalty of $60,000, or $15,000 per fiscal quarter from 2024 to 2025. Therefore, no additional minimum royalty was required during 2024, but will be required beginning the fiscal first quarter of 2025. 2025 will be the final year of the additional minimum royalty under the STS agreement. On November 1, 2022 the Company issued to the designees of STS 1,155,881 shares of common stock with a fair value of $30,000 in accordance with the Patent License Agreement. Royalty recorded under the Amended agreement was $25,504 and $125,159 for the three months ended March 31, 2025 and year ended December 31, 2024

Consulting and Employment Agreements

On ~~August~~November 15, ~~2021~~2020, the Company ~~and Blake Carmichael~~ entered into a three-year employment agreement with Christopher Constable (the “~~Blake~~Constable ~~Carmichael~~ Employment Agreement”) pursuant to which Mr. ~~Carmichael~~Constable ~~served~~serves as Chief Executive Officer of ~~BLU3~~the Company. Previously, Mr. Constable had provided advisory services to the Company through an agreement with Brandywine LLC. In consideration for his services, ~~Blake Carmichael~~Mr. ~~received~~Constable shall receive (i) an annual base salary of $~~120~~200,000, payable in accordance with the customary payroll practices of the Company, and (ii) aupon ~~cash bonus equal to 5%~~ execution of the ~~net~~Employment ~~income~~Agreement ofand ~~BLU3,~~on ~~payable~~each ~~quarterly,~~anniversary ~~beginning~~of ~~with~~ the ~~first~~date ~~full calendar quarter after the execution~~ of the ~~agreement,~~Agreement ~~and~~during ~~(iii) upon execution of~~ the ~~Carmichael Employment Agreement~~term, a non-qualified immediately exercisable five-year ~~stock~~ option to purchase ~~3,759,400~~that number of shares atequal to $~~0.0399~~100,000 ~~33.3%~~of the value of ~~which~~the ~~shares~~Company’s ~~vest~~common ~~immediately,~~stock ~~33.3%~~at ~~vest~~an onexercise price ~~the~~equal ~~second~~to ~~anniversary,~~the ~~and~~market ~~33.3%~~price ~~vest~~of on the ~~third~~Company’s ~~anniversary~~common ofstock on the ~~agreement.~~date Inof ~~addition~~issuance. Accordingly, ~~Blake~~on ~~Carmichael~~November is5, ~~entitled~~2020, toMr. ~~receive~~Constable was aissued ~~five-year~~an ~~stock~~ option to purchase ~~up to 18~~5,~~000~~434,~~000~~783 shares of the common stock at an exercise price of $0.~~0399~~0184 per share ~~that~~and ~~will~~on ~~vest~~November ~~upon annual financial metrics based upon a revenue measurement~~5, ~~expediency measurement and an EBITDA measurement~~2021, Mr. AConstable ~~measurement~~ was ~~made~~issued ~~for~~an ~~the~~option ~~nine~~to ~~months~~purchase ~~ended September 30~~2, ~~2024~~403,846 ~~resulting~~shares inof nothe ~~additional~~Company’s ~~expense~~common ~~since~~stock ~~the~~at ~~vesting~~an ~~criteria~~exercise ~~were~~price ~~not~~of ~~met~~$0.0401 per share.

On September 3, 2021, SSI and Christeen Buban entered into a three-year employment agreement (the “Buban Employment Agreement”) pursuant to which Ms. Buban shall serve as the President of SSI. In consideration for her services, Mrs. Buban shall receive (i) an annual base salary of $110,000, payable in accordance with the customary payroll practices of the Company, (ii) a car allowance and cell phone allowance of $10,800 per year, (iii) a five-year option issued under the Plan to purchase 300,000 shares of common stock of the Company at $0.0531 per share, which option vests quarterly over the eight calendar quarters.

In addition, Mrs. Buban is entitled to receive a five-year stock option to purchase up to 7,110,000 shares of common stock of the Company at an exercise price of $0.0531 per share, which vests upon the attainment of certain defined annual financial metrics, as set forth in the Buban Employment Agreement. A measurement was made for the three months ended September 30, 2024 and no expense was recorded based upon the vesting criteria not being met.

OnIn ~~January 17~~addition, ~~2022~~Mr. Constable shall be entitled to receive four-year 4 stock options to purchase shares of common stock at an exercise price equal to $0.0184 per share in the following amounts based upon the following performance milestones during the term of the Constable Employment Agreement: (i) 2,000,000 shares – if the Company’s ~~entered~~total ~~into~~net anrevenues, ~~agreement~~as ~~with~~reported ~~The~~in ~~Crone~~its ~~Law~~statement ~~Group~~of operations in its financial statements in its filings with the SEC, PCincluding as a result of a stock or asset acquisition of a third party (“~~CLG~~Net Revenues”) ~~for~~are ~~the~~in ~~provision~~excess of ~~legal~~$5,000,000, ~~services. In~~in ~~consideration~~the ~~therefore~~aggregate, ~~the~~for ~~Company~~four ~~will~~consecutive ~~pay~~fiscal ~~CLG~~quarters; a(ii) ~~monthly~~3,000,000 ~~flat~~shares ~~fee~~– if the Company’s Net Revenues are in excess of $37,500,000, in the aggregate, for ~~SEC~~four ~~reporting~~consecutive ~~work~~fiscal ~~and~~quarters; ~~its~~(iii) ~~normal~~5,000,000 shares ~~hourly~~– ~~rate~~if the Company’s Net Revenues are in excess of $10,000,000, in the aggregate, for ~~other~~ ~~legal~~four ~~work~~consecutive fiscal quarters; and ~~issued~~(iv) 120,000,000 shares of– if the Company’s common stock ~~with~~is alisted ~~fair~~on ~~market~~the ~~value~~NASDAQ ofor ~~$27,500~~New toYork ~~CLG~~Stock Exchange.

On ~~May~~June 224, ~~2022~~2023, ~~the Company entered into a two-year employment agreement with Steven Gagas (the “Gagas Employment Agreement”) pursuant to which~~ Mr. ~~Gagas~~Constable ~~shall~~resigned ~~serve~~ as ~~the~~Chief ~~General~~Executive ~~Manager~~Officer of the ~~dive~~Company ~~shop~~effective ~~currently~~July ~~operating~~7, ~~within~~2023 ~~LBI~~. ~~In consideration for his services Mr. Gagas shall receive an annual salary of $50,000.~~

On ~~May~~August 21, ~~2022~~2021, ~~LBI,~~the Company and Blake Carmichael entered into a ~~lease~~three-year ~~assignment~~employment agreement ~~with~~(the ~~Gold~~“Blake ~~Coast~~Carmichael ~~Scuba~~Employment Agreement”) pursuant to which Mr. Blake Carmichael shall serve as Chief Executive Officer of BLU3. In consideration for his services, Blake ~~LLC~~Carmichael ~~and~~shall ~~Vicnsons~~receive ~~Realty~~(i) ~~Group~~an annual base salary of $120,000, ~~LLC~~payable ~~whereby~~in ~~LBI~~accordance is with the ~~assignee~~customary payroll practices of the Company, and (ii) a ~~three~~cash ~~year~~bonus ~~lease~~equal ~~for~~to 5% of the ~~property~~net ~~located~~income atof ~~259~~BLU3 ~~Commercial~~payable ~~Blvd.~~quarterly, ~~Suites~~beginning 2with ~~and~~the 3first infull ~~Lauderdale-By-The~~calendar ~~Sea, Florida~~quarter ~~for~~after ~~$2,816~~the ~~per~~execution ~~month~~of ~~base~~the ~~rent~~agreement. ~~The~~(iii) ~~lease~~upon ~~expired~~execution onof ~~March~~the 31Employment Agreement, ~~2023~~a ~~and~~non-qualified ~~LBI~~five-year isstock ~~currently~~option ~~renting~~to purchase 3,759,400 shares at $0.0399, 33.3% of which shares vest immediately, 33.3% vest on athe ~~month~~second toanniversary, ~~month~~and ~~basis~~33.3% ~~LBI~~vest ~~has~~on the third ~~option~~anniversary toof ~~renew~~ the ~~lease~~agreement. ~~for~~This aagreement ~~two~~automatically renews for one year term ~~with~~unless aneither ~~increase~~party ofgive ~~base~~a ~~rent~~30 ofday 3notice.~~5%.~~

OnIn ~~September 14~~addition, ~~2022,~~Blake ~~SSI~~Carmichael ~~entered~~shall ~~into~~be aentitled ~~sixty-month~~to ~~lease~~receive ~~renewal~~a ~~for~~five-year ~~its~~5 ~~facility~~stock inoption ~~Huntington~~to ~~Beach,~~purchase ~~California~~up ~~commencing~~to ~~on February 1~~18,000,000 ~~2022~~shares ~~with base rent~~ of ~~approximately~~common stock ~~$17,550~~at ~~per month for the first 24 months with~~ an ~~annual~~exercise ~~escalation~~price ~~clause~~ of 3.$0~~% thereafter~~. ~~Obligations~~0399 ~~under~~per ~~the~~share ~~lease~~that ~~are~~will ~~guaranteed~~vest byupon ~~the~~annual ~~Company.~~financial ~~The~~metrics ~~Company~~based ~~paid~~upon ana ~~additional~~revenue ~~security deposit of $10~~measurement,~~727~~ ~~upon~~expediency measurement ~~entering~~and ~~into the~~an ~~lease~~EBITDA measurement.

On September 303, ~~2022~~2021, SSI and Christeen Buban entered into a ~~sublease~~three-year ofemployment ~~its~~agreement ~~facility~~(the in“Buban ~~Huntington~~Employment ~~Beach,~~Agreement”) pursuant ~~California~~to ~~with~~which ~~Camburg~~Ms. ~~Engineering~~Buban shall serve as the President of SSI. In consideration for her services, ~~Inc~~Mrs. Buban shall receive (~~“Tenant”~~i) an annual ~~commencing~~base ~~October~~salary 1,of ~~2022~~$110,000, payable ~~The~~in ~~term~~accordance ofwith the ~~sublease~~customary ispayroll ~~through~~practices ~~December~~of ~~31,~~the ~~2023~~Company, ~~with~~(ii) a ~~base~~car ~~monthly~~allowance ~~rent~~and cell phone allowance of $210,~~247~~800 per ~~for~~year, ~~the~~(iii) ~~first~~a ~~twelve months~~five-year ~~with~~5 aoption 3%issued ~~annual~~under ~~escalation~~the Plan ~~thereafter.~~to ~~The~~purchase ~~Tenant~~300,000 ~~also~~shares ~~pays~~of acommon ~~monthly~~stock ~~common~~of ~~area~~the ~~maintenance~~Company ofat $~~112~~0.0531 ~~The~~per ~~Tenant~~share, ~~provided~~which aoption vests quarterly over the eight calendar ~~security~~quarters ~~deposit~~for ofone ~~$2,426~~year ~~upon~~term ~~entering~~unless ~~into~~either ~~the~~party ~~sublease~~give a 30 day notice.

OnIn ~~December 22~~addition, ~~2022, the U~~Mrs.S. ~~Consumer~~Buban ~~Products~~shall ~~Safety~~be ~~Commission~~entitled ~~(the~~to ~~“CPSC”)~~receive ~~issued~~ a ~~voluntary~~five-year ~~recall~~5 ~~notice~~stock ~~for~~option ~~the~~to ~~Nomad tankless~~purchase ~~dive~~up ~~system,~~to ~~which is distributed by BLU3~~7,110,000 shares ~~Inc.~~of Ascommon ~~part~~stock of the ~~recall procedure, the CPSC has approved the~~ Company’s ~~proposed remedy~~at ~~for~~an ~~the~~exercise ~~recall and BLU3 received units back from consumers to repair affected Nomad units. The Company has evaluated the costs~~price of ~~this recall and has deemed it necessary to set an allowance of~~ $~~160~~0.0531 per share,~~500~~ ~~for~~which ~~such~~vests ~~costs.~~upon ~~During~~ the ~~twelve~~attainment ~~months~~of ~~ended~~certain ~~December 31,~~defined ~~2023~~annual ~~the~~financial ~~Company~~metrics, ~~repaired~~as ~~and~~set ~~returned~~forth ~~653 units to customers resulting~~ in ~~a reduction of~~ the ~~allowance~~Buban ofEmployment ~~$93,161 for the twelve months ended December 31, 2023~~Agreement.

~~Note~~On 9May 2, 2022, the Company entered into a two-year employment agreement with Steven Gagas (the “Gagas Employment Agreement”) pursuant to which Mr. ~~Subsequent~~Gagas ~~Events~~shall serve as the General Manager of the dive shop currently operating within LBI. In consideration for his services Mr. Gagas shall receive an annual salary of $50,000. The agreement terminated upon Mr. Gagas’ retirement in January 2024.

~~The~~On January 17, 2022, the Company ~~has~~entered ~~completed~~into an ~~evaluation~~agreement ofwith ~~all~~The ~~subsequent~~Crone ~~events~~Law ~~through~~Group, ~~November~~PC ~~19,~~(“CLG”) ~~2024~~for the provision of legal services. In consideration therefor, the ~~date~~Company will pay CLG a monthly flat fee of $3,000 for the ~~financial~~SEC ~~statements~~reporting ~~were~~work, ~~issued.~~and its normal hourly rate ~~Except~~for asany ~~described~~other ~~below~~legal work and issued 1,000,000 ~~the~~shares ~~Company~~of ~~has~~common ~~concluded~~stock ~~that~~with noa ~~subsequent~~fair ~~event~~market ~~has~~value ~~occurred~~of ~~that~~$27,500 ~~requires~~to ~~disclosure~~CLG. Mr. Gagas retired in January, 2024

On December ~~November 13~~22, ~~2024~~2022, the ~~Company~~U.S. ~~and~~Consumer ~~Charles~~Products ~~Hyatt,~~Safety aCommission ~~director~~ (the “~~Hyatt~~CPSC”)~~, executed~~ ~~(i)~~issued ~~an amendment to~~ a ~~promissory~~voluntary ~~note~~recall innotice for the ~~principal~~Nomad tankless ~~amount~~dive ~~of $150~~system,~~000,~~ which ~~was~~is ~~originally~~distributed ~~issued~~ by ~~the~~BLU3, ~~Company~~Inc. toAs ~~Hyatt on~~part ~~November~~of ~~7, 2023 (~~the ~~“2023~~recall ~~Note”)~~procedure, tothe ~~extend~~CPSC approved the ~~2023 Note~~Company’s ~~maturity~~proposed remedy ~~date~~for ~~from~~the ~~May~~recall ~~7, 2024 to May 7, 2025,~~ and ~~(ii)~~ anBLU3 ~~amendment~~began to areceive ~~promissory~~units ~~note~~back infrom ~~the~~consumers ~~principal~~for ~~amount~~repair ofin ~~$280,000,~~[provide ~~which~~month ~~was~~and ~~originally~~year].. ~~issued~~The byCompany has evaluated the ~~Company~~costs toof ~~Hyatt~~this onrecall ~~February 5,~~and ~~2024~~has ~~(the~~deemed ~~“2024~~it ~~Note”),~~necessary to ~~extend~~set ~~the~~an ~~2024~~allowance ~~Note’s~~of ~~maturity~~$160,500 ~~date~~for ~~from~~such ~~August~~costs. 5,In 2024 ~~to May 5~~, ~~2025.~~the ~~Except~~Company asfinalized ~~specifically~~the ~~amended~~recall byand ~~the~~adjusted ~~amendments,~~ the ~~terms~~reserve ~~and~~down ~~conditions~~to ofzero ~~the~~reflecting ~~2023~~that ~~Note~~all ~~and~~expenses ~~2024~~related ~~Note~~to ~~remain~~the inrecall ~~full~~had ~~force~~been ~~and effect~~realized..

Legal

There are no outstanding legal issues as of June 27, 2025

Note 16. Subsequent Events

The maturity due date of the convertible notes has been verbally extended by the lender while the Company works through to determines a restructure of the notes.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing in this Quarterly Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report. Actual future results may be materially different from what we expect. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made, except as required by applicable law.

The management’s discussion and analysis of our financial condition and results of operations are based upon our unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

Overview

The Company owns and operates a portfolio of companies with a concentration in the industrial and recreational diving industry. The Company, through its subsidiaries, designs, tests, manufactures, and distributes recreational hookah diving, yacht-based scuba air compressors and nitrox generation systems and scuba and water safety products in the United States and internationally.

The Company has five subsidiaries focused on various sub-sectors:

● Brownie’s Third Lung - Surface Supplied Air (“SSA”) ● BLU3, Inc. - Ultra-Portable Tankless Dive Systems ● LW Americas - High Pressure Gas Systems ● Submersible Systems, Inc. - Redundant Air Tank Systems ● Live Blue, Inc. – Guided Tours and Retail

Our wholly owned subsidiaries do business under their respective trade names on both a wholesale and retail basis from our headquarters and manufacturing facility in Pompano Beach, Florida, a manufacturing facility in Huntington Beach, California, and a retail facility in Lauderdale-By-The-Sea, Florida.

The Company, through its wholly owned subsidiaries, designs, tests, and manufactures tankless dive systems, rescue air systems and yacht-based self- contained underwater breathing apparatus (“SCUBA”) air compressor and nitrox generation fill systems. In addition, the Company is the exclusive distributor for North and South America for Lenhardt & Wagner GmbH (“L&W”) compressors in the high-pressure breathing air and industrial gas markets. The Company is also building a guided tour operation that includes dive retail. Lastly, The Company is the exclusive United States and Caribbean distributor for Chrysalis Trading CC, a South African manufacturer of fitness and dive equipment, doing business as Bright Weights (“Bright Weights”), of a dive ballast system produced in South Africa.

Recent Development

On November 13, 2024, the Company and Charles Hyatt, a director (“Hyatt”), executed (i) an amendment to a promissory note in the principal amount of $150,000, which was originally issued by the Company to Hyatt on November 7, 2023 (the “2023 Note”), to extend the 2023 Note’s maturity date from May 7, 2024 to May 7, 2025, and (ii) an amendment to a promissory note in the principal amount of $280,000, which was originally issued by the Company to Hyatt on February 5, 2024 (the “2024 Note”), to extend the 2024 Note’s maturity date from August 5, 2024 to May 5, 2025. Except as specifically amended by the amendments, the terms and conditions of the 2023 Note and 2024 Note remain in full force and effect.

Results of Operations

Net Revenues, Costs of Net Revenues and Gross Profit

Three Months Ended September 30, 2024 Compared to Three Months Ended September 30, 2023

Net revenues increased 8.2% for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023 as a result of an increase in revenues in BLU3, SSI, and LWA. Net revenue for BLU3 SSI, and LWA increased 25.1%, 42.8%, and 12.5%, respectively. The increase in BLU3’s revenue is due to the recovery from the recall that directly affected the previous period’s revenues. SSI’s increase can be attributed to the continued momentum of the Company’s newest product, HEED3 as well as increased demand from international users of SSI’s Spare Air product line. The increase in BLU3, SSI and LWA’ revenue was offset by decreased revenues in BTL, and LBI. Net revenue for BTL, and LBI decreased 13.9%, and 50.9%, respectively, as a result of a loss of sales momentum as well as a soft demand in many areas of BTL, and LBI’s markets.

For the three months ended September 30, 2024, cost of net revenues was 55.3% as compared with the cost of net revenues of 67.7% for the three months ended September 30, 2023. The cost decrease as a percentage of revenue, can be directly attributed to the cost of direct labor, which accounted for a larger portion of costs and significantly impacted the profit margin. Included in cost of net revenues are royalty expenses paid to Robert Carmichael which increased 1.9% for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023.

Gross profit margin was 44.7% for the three months ended September 30, 2024 as compared to gross profit margin of 32.3% for the three months ended September 30, 2023. The increase in gross margin, is directly attributable to an increase in SSI’s margin to 63.0% primarily attributed to SSI’s newest product, HEED3, and reduced manufacturing labor positively impacting gross margin.

Nine Months Ended September 30, 2024 Compared to Nine Months Ended September 30, 2023

Net revenues increased 4.9% for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023 as a result of an increase in revenues in BLU3 and SSI. Net revenue for BLU3 and SSI increased 29.0% and 39.0%, respectively. The increase in BLU3’s revenue is due to the recovery from the recall that directly affected the previous period’s revenues. SSI’s increase can be attributed to the continued momentum of the Company’s newest product, HEED3, and increased demand from international users of SSI’s Spare Air product line. The increase in BLU3 and SSI’ revenue was offset by decreased revenues in BTL, LWA, and LBI. Net revenue for BTL, LWA, and LBI decreased 19.6%, 9.3%, and 47.3%, respectively, as a result of a loss of sales momentum as well as a soft demand in many areas of BTL, LWA, and LBI’s markets.

For the nine months ended September 30, 2024, cost of net revenues was 59.5% as compared with the cost of net revenues of 70.4% for the nine months ended September 30, 2023. The cost decrease as a percentage of revenue, can be directly attributed to the cost of direct labor, which accounted for a smaller portion of costs and significantly impacted the profit margin. Included in cost of net revenues are royalty expenses paid to Robert Carmichael which decreased 8.5% for the nine months ended September 30, 2024, as compared to the nine months ended June 30, 2023.

Gross profit margin was 40.5% for the nine months ended September 30, 2024, as compared to gross profit margin of 29.6% for the nine months ended September 30, 2023. The increase in gross margin is directly attributable to increased margins for SSI, LWA and LBI primarily attributed to SSI’s newest product, HEED3, and reduced manufacturing labor positively impacting gross margin.

Operating Expenses

Operating expenses consist of selling, general and administrative (“SG&A”) expenses and research and development costs and are reported on a consolidated basis for our operating segments. Operating expenses increased 12.1% and 13.2%, respectively, for the three and nine months ended September 30, 2024 as compared to the same periods in the prior year.

Selling, General & Administrative Expenses (SG&A Expenses)

SG&A increased by 13.1% for the three months ended September 30, 2024, and 13.3% for the nine months ended September 30, 2024, when compared to the same periods in the prior year. SG&A expenses were comprised of the following:

Expense Item	Three Months Ended September 30, 2024		Three Months Ended September 30, 2023		% Change			Nine Months Ended September 30, 2024		Nine Months Ended September 30, 2023		% Change
Payroll, Selling & Administrative	$	458,987	$	459,444		(0.1	)%	$	1,379,320	$	1,336,543		3.2	%
Stock Compensation Expense		-		7,185		(100.	)%		12,423		25,404		(51.1	)%
Professional Fees		14,455		20,568		(29.8	)%		190,995		120,427		58.6	%
Advertising		83,741		129,970		(35.6	)%		270,978		330,989		(18.1	)%
All Other		356,187		190,622		86.9	%		782,446		513,027		52.5	%
Total SG&A	$	913,370	$	807,789		13.1	%	$	2,636,162	$	2,326,390		13.3	%

Payroll for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023 decreased 0.1%. Payroll for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023, increased 3.2%. The increase reflects additions in production personnel in BLU3, for the nine months ended September 30, 2024.

Non-Cash Stock Compensation expenses decreased by 100.0% and 51.1%, for the three and nine months ended September 30, 2024, respectively, as compared to the three and nine months ended September 30, 2023, as a result of vesting milestones based upon performance goals not being met for the three months and nine months ended September 30, 2024.

Professional fees, including legal, accounting and other professional fees decreased 29.8%, for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023. Professional fees, including legal, accounting and other professional fees increased 58.6% for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023. The increase can be attributed to an increase in legal fees of 47.3%, other professional fees of 176.0%, and accounting fees of 39.9%.

Advertising expense decreased 35.6% and 18.1% for the three and nine months ended September 30, 2024 as compared to the three and nine months ended September 30, 2023, respectively. This decrease is attributable to BLU3’s decrease in advertising online expenses. BLU3’s decrease in advertising expenses was offset slightly by an increase in trade show expenses.

Other expenses increased 86.9% and 52.5 % for the three and nine months ended September 30, 2024, as compared to the three and nine months ended September 30, 2023, respectively, due primarily to an increase in rent expenses.

Research & Development Expenses (R&D Expenses)

R&D expenses for the three and nine months ended September 30, 2024, decreased 99.5% and 5.4%, compared to the three months and nine months ended September 30, 2023, respectively, as a result of a decrease in new product development activity.

Other Income/Expense

For the three and nine months ended September 30, 2024 and 2023, other income/expense consisted solely of interest expense. For the nine months ended September 30, 2024, interest expense increased 2.0% from the nine months ended September 30, 2023 to approximately $57,000 as compared to approximately $56,000 in the nine months ended September 30, 2023. The increase in interest expense can be attributed to the NFS Leasing loan, the Navitas Credit Corp 2022 loan, and the convertible demand note from Robert Carmichael.

Liquidity and Capital Resources

We had cash of $646,481 as of September 30, 2024. The following table summarizes total current assets, total current liabilities, and working capital at September 30, 2024, as compared to December 31, 2023.

	September 30,		December 31,
	2024		2023		% change
		(unaudited)
Total current assets	$	3,655,216	$	2,736,601		32.9	%
Total current liabilities	$	3,230,411	$	2,502,787		27.1	%
Working capital	$	424,805	$	233,814		94.8	%

The increase in our current assets at September 30, 2024 from December 31, 2023 primarily reflected an increase in cash, accounts receivable and prepaid expenses. The increase in current liabilities reflects mainly an increase in customer deposits and related party notes payable.

Summary Cash Flows

	Nine Months Ended September 30,
	2024			2023
	(unaudited)
Net cash used in operating activities	$	(56,568	)	$	(367,628	)
Net cash used in investing activities	$	(14,251	)	$	(28,671	)
Net cash provided by financing activities	$	286,187		$	199,740

Net cash used in operating activities for the nine months ended September 30, 2024 was due to the net loss of approximately $82,000.

Net cash used in investing activities for the nine months ended September 30, 2024, of $14,251 consists of fixed asset purchases.

Net cash of $286,187 provided by financing activities for the nine months ended September 30, 2024, reflects the issuance of debt to a related party and proceeds from long term debt partially offset by the repayment of debt.

Going Concern

Our unaudited consolidated financial statements included in this Quarterly Report were prepared assuming we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of issuance of these consolidated financial statements. The report of our independent registered public accounting firm on our audited consolidated financial statements for the year ended December 31, 2023 includes an explanatory paragraph stating the Company has net losses and an accumulated deficit which raises substantial doubt about its ability to continue as a going concern. If the Company is unable to raise additional funds when needed, or does not have sufficient cash flows from sales, it may be required to scale back, delay or cease operations, liquidate assets and possibly seek bankruptcy protection.

We have a history of losses, and an accumulated deficit of $17,767,548 as of September 30, 2024. Despite a working capital surplus of $424,805 at September 30, 2024, the continued losses and cash used in operations raise substantial doubt as to the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to continue to increase revenues, control expenses, raise capital, and continue to sustain adequate working capital to finance its operations. The failure to achieve the necessary levels of profitability and cash flows would be detrimental to the Company. We are continuing to engage in discussions with potential sources for additional capital, however, our ability to raise capital is somewhat limited based upon our revenue levels, net losses and limited market for our common stock. If we fail to raise additional funds when needed, or if we do not have sufficient cash flows from operations, we may be required to scale back or cease certain of our operations.

Critical Accounting Policies

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the reported periods. The more critical accounting estimates include estimates related to revenue recognition, valuation of inventory, allowance for doubtful accounts, and equity-based transactions. We also have other key accounting policies, which involve the use of estimates, judgments and assumptions that are significant to understanding our results, which are described in Note 2 to our unaudited consolidated financial statements contained in this Quarterly Report.

Recent Accounting Pronouncements

There were various accounting standards and interpretations issued recently, none of which are expected to have a material effect on the Company’s operations, financial position or cash flows.

These recent accounting pronouncements are described in Note 2 to our unaudited consolidated financial statements contained in this Quarterly Report.

Off Balance Sheet Arrangements

We currently have no off-balance sheet arrangements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is a smaller reporting company and is not required to provide this information.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures” as such term is defined in Rule 13a-15(e) under Exchange Act. In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of disclosure controls and procedures are met. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Based on their evaluations as of September 30, 2024, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were not effective such that the information relating to our company, required to be disclosed in our Securities and Exchange Commission reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure as a result of continuing material weaknesses in our internal control over financial reporting described below. A material weakness is a deficiency, or combination of deficiencies, that results in more than a remote likelihood that a material misstatement of annual or interim financial statements will not be prevented or detected.

Our management, including our Principal Executive Officer and Principal Financial Officer, have evaluated the effectiveness of the design and operations of our disclosure controls and procedures (defined in Exchange Act Rules 13a-15(c) and 15d-15(e)) as of September 30, 2024 and based upon the such evaluation, have concluded that the disclosure controls and procedures were not effective as of such date due to the material weaknesses set forth below.

● Insufficient number and lack of qualified accounting department and administrative personnel and support; ● Insufficient written policies and procedures to ensure the correct application of accounting and financial reporting with respect to GAAP and SEC disclosure requirements; ● Insufficient segregation of duties, oversight of work performed and lack of controls in our finance and accounting functions due to limited personnel; ● Company’s systems that impact financial information and disclosures have ineffective information technology controls; ● Inadequate controls surrounding revenue recognition, to ensure that all material transactions and developments impacting the financial statements are reflected and properly recorded; and ● Evaluation of disclosure controls and procedures was not sufficiently comprehensive due to limited personnel.

Subject to sufficient resources, management expects to remediate the material weaknesses identified above as follows:

● Management has leveraged and will continue to leverage experienced consultants to assist with ongoing GAAP and SEC compliance requirements. We intend to expand our finance department through the hiring of a certified public accountant to strengthen the segregation of duties, internal controls and enhance our current staff. ● Segregation of duties is being analyzed and adjusted Company-wide, where possible. The Company intends to hire additional personnel in the accounting department, as well as the documentation of controls and procedures. ● The Company plans on evaluating various accounting systems to enhance its system controls.

We will continue to monitor and evaluate the effectiveness of our internal control over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow. We do not, however, expect that the material weaknesses in our disclosure controls will be remediated until such time as we have added to our accounting and administrative staff allowing improved internal control over financial reporting.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL ~~PROCEEDINGS~~PROCEEEDINGS

There are no pending legal proceedings to which we are a party or in which any director, officer or affiliate of ours, any owner of record or beneficially of more than 5% of any class of our voting securities, or security holder is a party adverse to us or has a material interest adverse to us.

ITEM 1A. RISK FACTORS

The Company is a smaller reporting company and is not required to provide this information.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Except as set forth below, there were no sales of equity securities sold during the period covered by this Report that were not registered under the Securities Act and were not previously reported in a Current Report on Form 8-K filed by the Company.

On ~~September~~March 3031, 2024, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on a convertible demand note.

The above issuance did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe ~~are~~isare exempt from the registration requirements of the Securities Act of 1933 by virtue of Section 4(2) thereof.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

None.

ITEM 5. OTHER INFORMATION

During the quarter ended ~~September~~March 3031, ~~2024~~2025, no director, officer or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements.

3024

ITEM 6. EXHIBITS

Exhibit
Number		Exhibit
31.1		Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32		Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

101.INS		Inline XBRL INSTANCE DOCUMENT
101.SCH		Inline XBRL TAXONOMY EXTENSION SCHEMA
101.CAL		Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF		Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB		Inline XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE		Inline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

3125

SIGNATURES

In accordance with the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 19, 2024	BROWNIE’S MARINE GROUP, INC.
Date: July 2, 2025	BROWNIE’S MARINE GROUP, INC.
	By:	/s/ Robert M. Carmichael
		Robert M. Carmichael
		Chief Executive Officer
		(Principal Executive Officer)
	By:	/s/ Robert M. Carmichael
		Robert M. Carmichael
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

3226

Filing Compare · Brownie's Marine Group, Inc